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INTRODUCTION 
Depression is a highly prevalent psychopathological condition, which affects 
millions of people worldwide and is predicted to increase. At the core of 
depression are negative affect and reduced ability to experience pleasure, and 
these features are expressed in passive coping strategies. The research of in-
volvement of monoamine systems in depression-related disorders has contri-
buted significantly to the knowledge of the pathophysiology and treatment of 
depression. Drugs that increase the synaptic availability of biogenic amines are 
in use to treat depression-related disorders, and the main targets in depression 
treatment are in serotonergic, dopaminergic and noradrenergic neurotrans-
mission. Nevertheless, other neurotransmitters are believed to have a major role 
in the pathogenesis of depression.  
Because many patients do not respond to the available drugs, and the first 
selected medicine often needs to be replaced, there is a need for more 
personalized medical approach. 
Studies of the neurochemistry underlying development of different affective 
states are becoming increasingly important. Individuals are differently affected 
by the interaction of the surrounding environment and genetic factors. Stressful 
life events, especially in the vulnerable early age, may lead to changes in 
neuronal systems and thereby greater susceptibility to e.g., addiction and 
depression. 
Animal models of affective disorders usually focus on states resembling fear, 
depressiveness, anxiety, neophobia and other expressions of negative affect but, 
in recent years, research has increasingly paid attention to positive affect. Using 
naturally occurring phenotypes in models for studying the inter-individual 
differences creates an opportunity to have a better understanding about beha-
viour, the affective states and nervous system functions, and inform modelling 
of human behaviour.  
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1. REVIEW OF LITERATURE 
1.1. Neurochemistry of depression 
Depression is a highly prevalent psychopathological condition that is charac-
terized by persistently lowered mood, loss of pleasure, and reduced energy, 
accompanied by changes in body weight, appetite, sleep rhythm, agitation or 
inhibition, feeling of worthlessness and guilt, distractibility, concentration 
difficulties and suicidal ideation (APA, 1994; WHO, 1992). Adverse life events 
are the most important causal factor in the development of depression. 
Susceptibility to distress is affected by genetic factors and the surrounding 
environment, which all together lead to changes in the central nervous system 
(CNS) that serve as the substrate of affective disorders. The variety of factors 
leading to depressive states has led to suggestions to consider multiplicity in 
analysing the pathogenesis of depression. Obviously, the heterogeneity of 
depressive syndromes means that not all depressed individuals are suffering 
from identical alterations in their brain (Harro and Oreland, 2001). 
Even though the symptoms of depression are well characterized, the 
underlying molecular mechanisms are largely unknown. The classic monoamine 
theory of depression suggests that a deficit in monoamine neurotransmitters in 
the synaptic cleft is the primary cause of depression (Coppen, 1967; Schild-
kraut, 1965). Much of the past 10–15 years of research on the neurochemistry of 
depression has led to considerable evidence implicating multiple systems, 
including all monoamines, particularly serotonin (5-HT), as well as several 
other neurotransmitter systems (Harro and Oreland, 2001; Sümegi, 2008).  
Despite the differences between species in their neuroanatomy and neuro-
chemical systems, the chemoarchitecture and connections of monoamine 
systems are largely comparable among mammals. This has frequently provided 
means for preclinical researchers to make successful predictions about human 
brain function (Harro and Oreland, 2001). 
 
 
1.1.1. Neurochemistry of monoamines and their role in depression 
Monoamine activity appears to be important in regulating many changes in 
neural function that underlie or enable shifts in behavioural functions, such as 
attention, motivation etc. Still, it is nonetheless possible to investigate experi-
mentally specific responses and effects of monoamines in specific brain areas 
where their modulatory functions may influence most directly some of the key 
behavioural components of the dimensions that are dysregulated in depression 
and anxiety disorders. Knowledge on the modulatory influence of monoamines 
in regions associated with depression is essential to understanding how 
alterations in those functions can contribute to the efficacy of antidepressants in 
the treatment of depression (Morilak and Frazer, 2004). The treatment of 
depression with antidepressants is achieved via the increase of the synaptic 
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availability of monoamines, and therefore an enhancement of neurotransmission 
(Coppen, 1967; Morilak and Frazer, 2004). 
Most often the serotonergic system has been implicated in mechanisms of 
anxiety and affective disorders. Selective serotonin reuptake inhibitors increase 
the extracellular levels of the 5-HT by inhibiting its reuptake into the 
presynaptic cell, hence increasing the levels of 5-HT in the synaptic cleft 
available to bind to the postsynaptic receptor (Millan, 2003; Morilak and Frazer, 
2004). The 5-HT transporter (5-HTT) function and 5-HT receptor levels are 
implicated in the pathophysiology of depression (Millan, 2003). For instance, 
different activity of 5-HT1B autoreceptors, which regulate the release of 5-HT 
by inhibitory feedback, have been hypothesized to be supersensitive in 
depression and anxiety (Moret and Briley, 2000). In adult mice, elimination of 
the 5-HT1A receptor has been shown to produce anxiety-type behaviour (Heisler 
et al., 1998). In general, the 5-HT1A receptor function seems to be lower in 
emotionally less stable animals (Harro, 2010). As to the 5-HT transporter levels 
and function, opposite findings have been obtained when different models, or 
different brain regions within a model, are compared (Harro, 2010). The study 
of Malison et al. (1998) showed that the 5-HTT availability was reduced in the 
depressed patients. 5-HTT sites on platelets have been found to be lower in 
depression by most, but not all researchers (Briley et al., 1980; Maes and 
Meltzer, 1995; Nemeroff et al., 1994). 
Aside the 5-HT, the noradrenaline (NA) system serves as a one of the targets 
in treatment of depression with antidepressants. NA deficiency, particularly in 
the pathways from the locus coeruleus (LC), the main source of NA-ergic 
projections, may affect working memory and cause psychomotor retardation. 
NA-ergic pathways are also involved in different emotional functions and 
believed to mediate stress response (Morilak and Frazer, 2004). 
Studies on depressed patients indicate that the NA reuptake inhibitors 
require the availability of NA, but not 5-HT, for their beneficial effects, and the 
converse is true for the selective serotonin reuptake inhibitors (Delgado and 
Moreno, 2000). However, NA-ergic action plays an important effect in different 
antidepressants, as confirmed by the efficacy of dual action antidepressants such 
as the serotonin and noradrenaline reuptake inhibitors, and noradrenaline and 
dopamine (DA) reuptake inhibitors that enhance the NA-ergic transmission. 
Therefore, it seems that the cause of depression is more complex than just an 
alteration in the levels of the 5-HT and/or NA (Delgado and Moreno, 2000). 
One model has proposed that primary defect emerges in the regulation of 
firing rates in brainstem monoaminergic neurons, which brings about a decrease 
in the tonic release of neurotransmitters in their projection areas, an increase in 
postsynaptic sensitivity, and concomitantly, exaggerated responses to acute 
increase in the presynaptic firing rate and transmitter release (Harro and 
Oreland, 2001). It is proposed that the initial defect involves, in particular, the 
NA-ergic innervation from the locus coeruleus. Dysregulation of the locus 
coeruleus projection activities may lead in turn to dysregulation of serotonergic 
and dopaminergic neurotransmission. Failure of the locus coeruleus function 
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could explain the basic impairments in the processing of novel information, 
intensive processing of irrational belief, and anxiety. Impairments in the 5-HT-
ergic neurotransmission may contribute to the mood changes and reduction in 
the dopaminergic activity to loss of motivation and anhedonia.  
Dopamine controls a variety of functions in the CNS, including locomotor 
activity, motivation and emotion, but probably the most acknowledged function 
of DA is its role in reward-related stimuli processing (Marsden, 2006). 
According to some theories, DA signals reward by mediating the learning signal 
that allows the system to predict better when rewards (e.g., food, sex, drugs) are 
likely to occur, and thereby contributes to the optimization of reward-seeking 
behaviours (Montague et al., 2004). Some of the symptoms of affective 
disorders that are improved by antidepressant drug treatment, for instance 
anhedonia, seem also related more to the DA-ergic function than 5-HT-ergic 
(Morilak and Frazer, 2004). Nevertheless, many antidepressants potently block 
the transporters mediating reuptake of 5-HT and/or NA, but not DA. The NA 
transporter may be the primary mechanism for DA reuptake in the frontal cortex 
(Morón et al., 2002) and drugs that block the NA transporter may also prevent 
the uptake of extracellular DA into NA-ergic terminals where the latter have 
much higher density (Pozzi et al., 1994). Preclinical studies have shown that 
noradrenaline uptake inhibitors elevate extracellular levels of DA in prefrontal 
cortex (PFC), but not in nucleus accumbens (NAcc) (Millan et al., 2000). By 
contrast, chronic treatment of rats with selective serotonin reuptake inhibitors 
did not elevate DA levels in PFC. On the other hand treatment with selective 
serotonin reuptake inhibitors and noradrenaline reuptake inhibitors enhances 
reward-related behavioural effects of DA in the NAcc, possibly through effects 
on mesolimbic DA neuronal activity (Bonhomme and Esposito, 1998).  
 
 
1.1.2. Neurochemistry of glutamate system and  
its role in depression 
Recent data from various studies have shown that amino acid neurotransmitters 
may also have a major role in the pathogenesis of depression (Gao and Bao, 
2011; Skolnick et al., 2009). In particular the glutamate system has been 
implicated in depression, leading to increased efforts to understand its 
machinery (Maeng et al., 2008; Skolnick et al., 2009; Tokita et al., 2012). 
Glutamate mediates a large part of the synaptic transmission in the CNS, is 
involved in the neurogenesis, and having a role in synaptic plasticity 
development is also important in cognitive functions like learning and memory 
(McEntee and Crook, 1993; McLennan et al., 1968). Upon stimulation of the 
nerve terminals, glutamate is released into the synaptic cleft and binds to 
glutamate receptors resulting in the propagation of an action potential. The 
regulation of glutamate in synaptic cleft is determined by frequent synaptic 
release and by localized glutamate uptake (Bergles et al., 1999; Clements et al., 
1992). There are two groups of glutamate receptors – ionotropic [NMDA (N-
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methyl D-aspartate), AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionic acid) and kainate] and metabotropic receptors. Ionotropic receptors 
operate via ion channels which allow the flow of cations (K+, Na+, Ca2+) in 
response to glutamate binding. Metabotropic receptors do not have ion 
channels, but mediate their functions via G-proteins, which then in turn trigger 
further second-messenger systems (Bleich et al., 2003). Five subtypes of 
glutamate transporters, EAAT1 to EAAT5, have been identified (Neuhauss et 
al., 2010). It is reported that glial glutamate transporter EAAT2 plays the largest 
role in regulation of extracellular glutamate levels (Danbolt et al., 1992; Tanaka 
et al., 1997; Shachnai et al., 2005), thus having the function to keep the 
glutamate concentration low in the extracellular space and to prevent excito-
toxic brain damage (Danbolt, 2001). L-trans-pyrrolidine-2,4-dicarboxylate 
(PDC) that works via blocking the glial glutamate transporter EAAT2 (Danbolt, 
2001) is considered to be the most efficient inhibitor (Bridges et al., 1991; 
Behrens et al., 2002; Del Arco et al., 2001).  
Matsugami et al. (2006), using an animal model in which this glutamate 
transporter was genetically deleted, demonstrated that EAAT2 is necessary for 
brain development through regulation of extracellular glutamate concentration. 
Behrens et al. (2002) observed that transgenic mice expressing an N-terminal 
fragment of mutant huntingtin (R6/2) had higher striatal glutamate levels 
compared with controls after inhibition by PDC. Additionally, in the R6/2 mice 
the decrease of EAAT2 mRNA expression compared to wild type group was 
also observed, obviously resulting in reduction of transporter function. Several 
studies have shown that chronically administered antidepressants from different 
classes modulate the function of NMDA receptor and its antagonists (e.g. 
ketamine) have been shown to possess antidepressant activity in animal models 
of depression (Sanacora et al., 2012; Skolnick et al., 2009). In depressed 
patients, the treatment with ketamine elicited antidepressant effects (Zarate et 
al., 2006). Additionally, relieving effect of ketamine on postoperative depres-
sive state and pain has been reported (Kudoh et al., 2002). Similarly, in animal 
studies, after stressful procedures (forced-swim test, learned helplessness), the 
antidepressant effects of ketamine-elicited appeared and the pretreatment with 
AMPA receptor agonist (NQOX) attenuated ketamine antidepressant-like 
behaviour (Maeng et al., 2008). Moreover, recent studies suggest that the 
antidepressant-like effects of NMDA antagonists may be dependent on 
enhancement of AMPA receptor activation (Maeng et al., 2008; Sanacora et al., 
2012). Nevertheless, other studies question the universal need for AMPA 
receptor activation in relation to antidepressant properties of NMDA antagonists 
(Dybala et al., 2008; Popik et al., 2008).  
The olfactory bulbectomy is an established animal model of depression in 
rats. Ho et al. (2000) examined striatal glutamate levels in olfactory 
bulbectomized and sham-operated rats. In appeared that under (novelty) stress 
condition glutamate levels increased from the baseline value (up to 160%) in 
the case of olfactory bulbectomized rats. In learned helpless model, more 
helpless rats had a decrease of glutamate uptake in striatum and hippocampus 
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(Almeida et al., 2010). Additionally, as reduced expression of glutamate 
transporter of glia (EAAT2) has been observed in learned helplessness rats 
(Zink et al., 2010), it is suggested that glial cell abnormalities may at least partly 
account for the impairment in glutamate action (Kugaya and Sanacora, 2005). 
Altered levels of glutamate have been seen in cortico-limbic structures found to 
be dysregulated in depression (Sanacora et al., 2008). Acute stress is associated 
with increased glutamatergic neurotransmission in areas of the forebrain, and 
chronic treatment with antidepressant causes a reduction of glutamate release 
(Tokarski et al., 2008). Recent study by Musazzi et al. (2010) also showed that 
depolarization-dependent release of glutamate is selectively up-regulated by 
acute stress and that antidepressant treatment completely abolished this effect. 
There is evidence of various levels of interaction between glutamatergic and 
monoaminergic pathways and the antidepressant effects of the glutamatergic 
drugs can possibly be explained by a monoaminergic mechanism (Drago et al., 
2011). For instance, interaction of glutamatergic and dopaminergic neuro-
transmission in the striatum is well known (Smith and Bolam, 1990). Mora et 
al. (2003) showed that increasing levels of glutamate lead to increasing levels of 
DA in striatum, and blockade of ionotropic glutamate receptors attenuates the 
increase of DA levels. In substantia nigra, the spontaneously hypertensive rats, 
considered as an attention-deficit/hyperactivity disorder animal model, are more 
active in the open field (Warton et al., 2009). Additionally, these rats showed 
higher glutamate-stimulated DA release, suggesting that altered glutamate 
regulation of DA neurons may contribute to novelty response at different levels. 
Nevertheless, there are no single-valued interactions between dopaminergic and 
glutaminergic transmission (David et al., 2005).  
The 5-HT system involvement in depression is well demonstrated, but the 5-
HT depletion alone does not decrease mood (Ruhé et al., 2007). This could be 
caused by a more complex biological liability, a part of which may be 
embedded in the glutamatergic-monoaminergic balance (Krystal et al., 2002; 
Skolnick et al., 2009). The downregulation of the adrenergic receptors or the 
enhancement of the serotonergic function is also associated with the admi-
nistration of the glutamatergic drugs (Lejeune et al., 1994; Pallotta et al., 1998). 
Stressful experiences have been found to increase the release both of NA 
(Miyashita and Williams, 2004) and glutamate (McEwen et al., 1997) in 
hippocampus. Thus, the nature of the effects of glutamate-mediated trans-
mission on the monoamine systems is dependent on the brain regions. 
 
 
1.2. Stress as the cause/trigger of depression 
Stressors are physical and psychological events that are the part of everyday life 
of humans and animals (McEwen, 2007). Different stressful life events (for 
example, loss of a close person) can either trigger or cause depressive episodes. 
Several clinical and epidemiological studies have presented that most episodes 
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of depression are preceded by stressful life events (Brown, 1998; Hammen, 
2005; Monroe et al., 2007). 
In animal models, different types of stressors are used dependent on which 
purpose the stressor should serve. The stressors are conditionally classified as 
systemic (involving an immediate physiologic threat e.g., low temperature or 
wet cage) and progressive (involving high-level cognitive processing e.g., 
novelty). Additionally the stressors can include or not various social stressful 
conditions (e.g., social defeat, maternal separation), and differ in duration - 
short (e.g., tail pinch) and longer impacts (e.g., overnight lighting) (Harro et al., 
2001; Herman and Cullinan, 1997; Katz et al., 1981; Willner, 2005).  
Aversive experiences give rise to behavioural attempts to cope with the 
stressors. When behavioural coping is possible, neurochemical systems are not 
overly taxed, and behavioural pathology will not occur (Anisman and Zacharko, 
1982). A major element in determining the neurochemical changes is the ability 
of organism to cope with the aversive stimuli through behavioural means. 
Reciprocally, the effects of stressful experiences on affective state may be 
related to depletion of several neurotransmitters. If the effect of stressors is 
long-lasting, it might lead to changes in neuronal, hormonal and immune 
systems and thereby greater susceptibility to psychiatric disorders (McEwen, 
2007). 
 
1.2.1. Neurochemical alterations after chronic stress 
A wide variety of chronic stress procedures exists, so the following section will 
be restricted to studies with the chronic variable/mild stress paradigm that has 
become the most often used instrument in depression research. The main aim of 
chronic stress procedure developed originally by Katz et al. (1981) is to produce 
a depressed state by the variation and unpredictability of a number of stressors 
administered repeatedly over a long period of time (Muscat and Willner, 1992; 
Zurita et al., 1999). This concept rests on the assumption that stressors separa-
tely have no depression-like effect on behaviour, but act cumulatively all 
together (Muscat and Willner, 1992). The chronic variable stress (CVS) para-
digm consistently brings out behavioural and physiological signs of anhedonia 
and emotional reactions such as anxiety and fear that resemble some of the 
symptoms of endogenous depression in humans (Bekris et al., 2005; Katz, 
1982; Willner, 2005; Zurita et al., 1999). The animals are subjected to the 
stressors over a period of several weeks which results in changes in activity 
levels in tests used in depression and anxiety studies, which are reversible by 
antidepressant treatment (Katz, 1982; Willner, 2005).  
As already mentioned, stressful situations might lead to greater vulnerability 
to different disorders, like depression, which still does not appear in all humans. 
Additionally, depression-related studies with rats and mice are consistent with 
this notion (Anisman and Zarharko, 1990; Nielsen et al., 2000), suggesting that 
there is a systematic inter-individual variability in the sensitivity to chronic 
stress. Studies with chronic stress have shown its various effects on behaviour, 
including a decrease in hedonic behaviour as measured by sucrose preference 
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tests; decreased sexual behaviour; reduction of active coping behaviour in the 
forced swimming test and increased freezing in case of fear stimuli (Grønli et 
al., 2005; Katz, 1982; Willner, 2005).  
Chronic multi-stressor treatment induces changes in neurotransmitter levels 
(Chaouloff, 2000; Harro and Oreland, 2001). Many investigations suggest that 
anxiogenic stimuli elicit release of 5-HT (File et al., 2000), while chronic 
variable stress profoundly affects hippocampal 5-HT-ergic neurotransmission in 
this region, especially in the dentate gyrus (DG) (Joëls et al., 2004; McKittrick 
et al., 1995). Nevertheless, distinct 5-HT-ergic pathways can make different 
contributions (Millan, 2003; Morilak and Frazer, 2004). Stress related 
physiology also includes the hypothalamus as chronic unpredictable stress 
increased 5-HT-ergic activity in this brain area (Cox et al., 2011). Additionally, 
both 5-HT and DA neurotransmission are suggested to be related to the 
development of stress-induced anhedonia. Bekris et al. (2005) found that in PFC 
DA-ergic activity increased following chronic stress. In the same area, 5-HT-
ergic activity was found to decrease, but increase in hippocampus. What may 
need to be considered is the non-linearity of connections between 5-HT-ergic 
activity and affective state of the animal: both increased and decreased 5-HT-
ergic neurotransmission have been associated with negative emotionality within 
a paradigm (Harro and Oreland, 2001; Tõnissaar et al., 2004). 
The stress response is mediated by an increased release of glucocorticoids 
via the activation of the hypothalamic-pituitary-adrenal (HPA) axis (Arborelius 
et al., 1999; Kendler et al., 1999; Koob, 1999; Munck et al., 1984). The HPA 
system is the common pathway in the mediation of the stress response and 
changes in the balance of HPA axis are considered to be characteristic to 
depression (Holsboer, 2000). It is reported that in rats acute or chronic stress 
increases the levels of plasma corticosterone (Grippo et al., 2005; Strausbaugh 
et al., 1999), similar to the human cortisol response (Römer et al., 2009). 
Increased activity of corticotropin-releasing factor (CRF) system is considered 
to be a marker of depression because HPA axis hyperactivity normalizes 
following antidepressant treatment. The administration of CRF directly into the 
CNS to laboratory animals causes behavioural and physiological changes 
almost identical to those observed by stressful stimuli, including increased heart 
rate, suppression of exploratory behaviour in an unfamiliar environment, 
decreased food intake and decreased sexual behaviour (Koob et al., 1993; 
Owens and Nemeroff, 1991). Although clinical studies have not shown 
consistent changes in cerebrospinal fluid concentrations of CRF in patients with 
anxiety disorders, still, preclinical findings strongly indicate a role for CRF in 
the pathophysiology of certain mood disorders, probably through its effects on 
central NA-ergic systems (Sauvage and Steckler, 2001). 
Various non-aminergic mechanisms, like neurotrophins, have been also 
implicated in depression (Castrén et al., 2007). Brain-derived neurotrophic 
factor (BDNF), nerve growth factor (NGF), neurotrophin-3 and neurotrophin-4 
are called neurotrophins, a family of secreted growth that promote to survival, 
maintenance of specific neuronal populations and regulate activity-dependent 
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synaptic plasticity (Bibel and Barde, 2000; Castrén et al., 2007). BDNF 
deficiency is believed to lead to a number of pathologies, including depression 
and anxiety-related behaviour (Binder and Scharfman, 2004; Martinowich and 
Lu, 2008). In depressed patients lowered BDNF levels have been reported in 
hippocampus and prefrontal cortex, the brain areas which have received special 
attention in animal research of depression and antidepressants (Dranovsky and 
Hen, 2006). Similarly, in animals, lower BDNF levels were obtained after 
chronic stress (Berton et al., 2006; Lee et al., 2010). BDNF signalling plays an 
important role in mechanisms of antidepressant action, as treatment with 
antidepressant drugs restores normal BDNF content (Hashimoto, 2010). Anti-
depressant drug treatment is efficient in normalizing many of the behavioural 
and neurochemical variations induced by chronic multiple stressors (Bekris et 
al., 2005; Bondi et al., 2007; Willner, 2005). 
 
 
1.2.2. Neurochemical alterations after early life stress 
Early life stress has long been thought to contribute to the pathophysiology of 
affective disorders (Holmes et al., 2005). Studies with early life stress have 
indicated major changes in neuroplasticity, which refer to the ability of neurons 
to alter some functional property in response to alternations in input (Gillick 
and Zirpel, 2012; Shaw et al., 1994). Early social interactions, including attach-
ment to the mother, are known to be essential, not only for establishment of 
social behaviour but also for normal physiological development (Hofer, 1994). 
Manipulations during the three first postnatal weeks thus alter these develop-
mental processes.  
 The rodent maternal separation (MS) model is a commonly used animal 
experimental model in studies of the impact of the early environmental on 
physiological and behavioural functions later in life (Holmes et al., 2005). A 
number of studies have shown that separation of rat pups from their mothers 
during the early postnatal period produces permanent increases in anxiety-
related behaviour when the offspring are tested as adults (Huot et al., 2001; 
Pryce et al., 2001a, 2001b). Different maternal separation protocols are in use, 
but initial maternal separation model originates from studies by Otto Weininger 
(1954), who showed that short handling of the pups, for instance stroking their 
back for ten minutes, caused positive effects in adulthood. Later on, there have 
been studies including several modifications with different light cycles, 
temperatures, either individual or litter-wise separations with various durations 
(Lehmann and Feldon, 2000; Levine, 1957; Pryce and Feldon, 2003; Roman 
and Nylander, 2005; Zimmerberg and Sageser, 2011). Common maternal 
separation protocols consists of short maternal separation, where pups are 
separated for 3–15 min, and prolonged maternal separation lasting 180–360 min 
(Lehmann and Feldon, 2000; Moffett et al., 2007; Roman and Nylander, 2005; 
Zimmerberg and Sageser, 2011). Three different groups - the non-handled, 
handled but not separated, those reared as normal animal facility group - are 
used as a control group (Jaworski et al., 2005).  
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Maternal separation causes behavioural changes in rats: more activity in the 
open plus-maze, higher anxiety in elevated plus-maze and exaggerated acute 
stress response (Kalinichev et al., 2002; Lukas et al., 2011; Sanders and 
Anticevic, 2007; Zimmerberg and Sageser, 2011). A large number of studies 
have presented neurobiological differences in animals subjected to maternal 
separation. Decreased levels of DA were observed in frontal cortex, NAcc and 
amygdala (Arborelius and Eklund, 2007; Ploj et al., 2003a) decreased levels of 
5-HT in NAcc and amygdala (Arborelius and Eklund, 2007; Vicentic et al., 
2006) and decreased levels of NA in frontal cortex (Arborelius and Eklund, 
2007; Liu et al., 2000; Matthews et al., 2001). Additionally, there are maternal 
separation-induced effects in the glutamatergic system (Pickering et al., 2006). 
Maternal separation also includes effects on stress reactivity. The HPA axis is 
an essential component for individuals in capacity to cope with stress and its 
activation leads to elevated release of corticosterone, the levels of which are 
used as indicator of stress (de Kloet et al., 1999). It is reported that maternally 
separated rats had high HPA axis reactivity to acute stress and decreased 
glucocorticoid receptor levels (Aisa et al., 2007, 2008).  
The early environmental impact on voluntary ethanol consumption has been 
studied using a protocol with daily repeated litter-wise maternal separation for 
15 min (MS15) and 360 min (MS360) (Gustafsson et al., 2007; Ploj et al., 
2003a, 2003b; Roman and Nylander, 2005). Based on the results from these 
studies it was suggested that MS15 represents a protective and MS360 a risk 
environment. The MS15-rats have shown the low ethanol consumption and 
prefer low concentrations of ethanol in adulthood. The MS360-rats are 
characterized by higher propensity for high ethanol preference and consumption 
(Ploj et al., 2003a; Roman et al., 2003, 2005). 
 
 
1.3. Inter-individual differences in behaviour of rats: 
implications for depression and addiction research 
Inter-individual differences in behaviour of animals have been used in research 
of behavioural phenotype-based models. Phenotypes result from the genes as 
well as the influence of environmental factors and are defined as the composite 
of observable characteristics or traits of organisms. This “trait” is defined as a 
pattern of a specific behaviour, which differs between individuals, but which is 
relatively constant within subjects over time and situations (Amelang et al., 
2006). If these traits are stable in their expression, they create an opportunity to 
model human traits and different conditions by studying the underlying 
neurobiological mechanisms. This approach has helped to clarify mechanisms 
behind neurochemical and physiological measurements and thereby offers 
strategy for psychobiological research, including depression, anxiety and 
addiction research (Harro, 2010; Pawlak et al., 2008).  
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1.3.1. Inter-individual differences in exploratory behaviour 
Different animal models in research of human psychopathology have been used 
for many years and of these probably the most studied are the models of 
depression. At the core of depression are negative affect and reduced ability to 
experience pleasure, and these features are expressed in passive coping 
strategies, including low exploratory activity in novel environments (Harro, 
2010).  
Novelty-related behaviour, usually called exploratory behaviour, is evoked 
by novel stimuli and it consists of behavioural acts and postures that permit the 
collection of information about new objects and unfamiliar parts of the 
environment (Crusio and van Abeelen, 1986; File and Hyde, 1978). Exploratory 
behaviour in animals is essential for survival due to the enhanced possibilities it 
provides to find food, water, mating partner, shelter etc (Berlyne, 1950). In 
situation, where animals are in a novel environment, their behaviour is in-
fluenced by two conflicting motivations to explore the unknown, the potentially 
dangerous environment, or to stay in secure and familiar surroundings. Thus, 
behavioural activity of an animal in a novel context is always a function of its 
curiosity and neophobia (Belzung, 1999; Harro, 1993).  
There are various approaches to measure the exploratory behaviour in rats 
(Harro, 1993, for review). In general, they are divided in two groups: ‘free’ 
tests, where animals have a choice of environments differing in the degree of 
novelty, and ‘forced’ tests, where locomotor response is assessed in animals 
placed into novel inescapable environments. The classical open-field test is 
probably the most widely used (Prut and Belzung, 2003), representing the 
forced access to novelty. However, it has been pointed out that this might be 
stressful as corticosterone levels in rats increase in response to an exposure to 
an open field (Marin et al., 2007), but not to free-choice novelty (Misslin et al., 
1982).  
Probably the most studied aspects of inter-individual differences of beha-
viour in animals are related with to exploratory behaviour and anxiety 
(reviewed in Pawlak et al., 2008). The paradigm most influential in studies of 
inter-individual differences overall has been the low/high responder (LR/HR) 
model that is based on locomotor/exploratory activity in a novel environment: 
rats (Sprague-Dawley) were classified based on median split of their two-hour 
locomotor activity in a novel inescapable circular corridor (Piazza et al., 1989, 
1991). Hereafter, the low and high responder phenotypes have been used often 
by a number of research groups, measuring activity in an inescapable novel 
environment, that can vary from a small novel photocell-equipped plexiglas 
cage to a large open field (Chefer et al., 2003; Hooks et al., 1991, 1994a; 
Verheij et al., 2009). Recently, bred lines of low and high responders were 
introduced (Stead et al., 2006). While in the original LR/HR studies the focus 
was put on prediction of individual levels of drug-seeking behaviour, the 
phenotype has a general significance to novelty and exploration: the HR-rats 
prefer more novel and modified environments in case of free choice between 
familiar and novel, and also exhibition lower levels of anxiety compared to LR-
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rats (Dellu et al., 1993; Kabbaj et al., 2000; Piazza and Le Moal, 1997; Verheij 
et al., 2009).  
As another alternative to the LR/HR paradigm and the plus-maze selection 
studies (e.g. Harro et al., 1990; Landgraf et al., 2007; Schwarting and Pawlak 
2004), the exploration box test (Harro et al., 1995; Otter et al., 1997) was 
developed to measure novelty-related behaviour in rats. During testing, the rat 
has a free choice either to stay in the dark home-cage-like chamber or to explore 
a large open area that has novel objects in it (Otter et al., 1997). This test yields 
a rather bimodal distribution based on the sum of exploratory activity, and thus 
separates the animals tested into groups with persistently high neophobia/low 
motivation and low neophobia/high motivation (low exploring and high 
exploring rats, LE- and HE-rats, respectively) with relatively few animals 
occupying the middle ground. These characteristic traits are consistent over 
time. We have shown that LE-rats are more anxious in plus-maze test and 
display more passive coping strategies in the forced swimming test (Mällo et 
al., 2007a). Additionally, the LE- and HE-rats have distinct cerebral metabolic 
activity in areas that are involved in defensive behaviours and cognitive 
processing of sensory stimuli (Matrov et al., 2007), furthermore, they differ in 
gene expression patterns, e.g. involving several glutamatergic and serotonergic 
genes in brain regions implicated in mood disorders (Alttoa et al., 2010).  
Several neurochemical measures have been shown to be associated with 
inter-individual differences in response to novel stimuli. Compared to low 
responders to novelty, high responders have higher baseline and stimulated DA 
release in the NAcc (Hooks et al., 1991; Rougé-Pont et al., 1998) and 
additionally, lower density of D2 receptor mRNA in the NAcc and the striatum 
(Hooks et al., 1994b). It has been reported that after mild stress of an exposure 
to a novel environment, HR-rats exhibit a prolonged corticosterone response 
and higher stress-induced levels of mesolimbic DA neurotransmission (Dellu et 
al., 1996; Piazza et al., 1989). Thiel et al. (1999) reported that in their LR/HR-
rat model, which is based on the vertical activity (rearings) in a novel open 
field, HR-rats have higher DA levels in ventral striatum and lower 5-HT 
concentration in the medial prefrontal cortex. Differences in NA system have 
been also associated with its hippocampal release in stressful conditions 
(Rosario and Abercrombie, 1999). It has been also demonstrated that inter-
individual variations exist in the glutamatergic system if animals with different 
novelty-related behaviour are compared. Shakil et al. (2005) examined striatal 
glutamate baseline levels in mice with low vs high locomotor responses to 
novelty, and found low responders mice to have on average 35% higher 
baseline extracellular glutamate levels. 
The exploration box test was originally developed in order to have a suitable 
tool for assessing behaviour of animals with LC denervation. While the LC 
activity closely follows any change in surroundings, the effects of near 
complete LC denervation had been found surprisingly hard to detect in standard 
tests, as the inter-individual variability of response increased. Indeed, intact 
NA-ergic projections ascending from the LC have were found to be very 
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important for normal exploration in rats using this test, as after destruction of 
these projections a very significant increase of neophobia was observed, but 
also reduction in motivation to explore (Harro et al., 1995). Indeed, extensive 
denervation by neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine 
(DSP-4) treatment rendered virtually all rats LE-like. 
The locus coeruleus gives rise to the dorsal NA-ergic bundle, which projects 
to many brain regions, being the only source of NA in the cortex and 
hippocampus (Robinson et al., 1977). The neurotoxin DSP-4 has a selective 
effect on NA-axonal terminal fields originating from the LC (Grzanna et al., 
1989; Jonsson et al., 1981) and thus can serve a valuable tool in studies of 
functional significance of LC-derived NA in the brain. Previously, we have 
found that both behavioural and neurochemical responses to NA-ergic depletion 
are dose-dependent and in some cases bidirectional. Usually smaller dose  
(10 mg/kg) of DSP-4 reduces NA levels by 30%, and enhances immobility time 
in the forced swimming test, whereas the near complete denervation achieved 
with doses 30–50 mg/kg reduced immobility (Harro et al., 1995; Harro and 
Oreland, 1996).  
It is well known that DA is participating in the locomotion activating and 
reinforcing effects of psychostimulants such as cocaine and amphetamine. 
Different studies have produced evidence that NA has also a substantial role in 
modulating psychostimulant-induced behaviours such as locomotor activity and 
reward (Tassin, 2008; Weinshenker and Schroeder, 2007). Up till now, there are 
only a few studies investigating the possible role of NA in psychostimulant-
induced conditioned place preference. Mice lacking the NA transporter develop 
a more pronounced conditioned place preference (CPP) to cocaine than controls 
(Xu et al., 2000). Concurrently, site targeted NA depletions produced by 
administration of 6-hydroxydopamine (6-OHDA) to neonatal rats, which caused 
a severe and long-lasting depletion of NA without affecting central DA content, 
were shown to not alter the CPP by cocaine (Spyraki et al., 1982). 
Although there is no doubt in NA-ergic involvement in psychostimulant-
induced behaviour, it is not clear which factors determine the exact role of NA 
in regulation of behaviour and in drug effects. Several studies utilizing beha-
vioural, biochemical and electrophysiological approaches have demonstrated 
NA-ergic stimulatory input from LC to the mesencephalic DA-ergic neurons 
(Andén and Grabowska, 1976; Grenhoff et al., 1993; Lategan et al., 1992). 
Additionally, the lesions of the LC can reduce DA release. Thus, alterations in 
the LC projection systems elicit lasting adaptive changes in DA-ergic neuro-
transmission that can serve as a substrate for psychiatric disorders. Altogether it 
appears that the response to novelty concept can be used in research of 
addiction, because these behaviours share some similar neurobiological 
substrate (Bardo et al., 1996; Blanchard et al., 2009), but many of the necessary 
pieces of the puzzle are still missing. 
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1.3.2. Addictive behaviour and inter-individual differences  
Addictive disorders such as alcoholism and drug addiction continue to be a 
substantial problem in society. According to American Society of Addiction 
Medicine (2011) the concept of addiction is defined as a primary, chronic 
disease of brain reward, motivation, and memory circuitries. Dysfunction in 
these circuits leads to characteristic biological, psychological, social and spiri-
tual manifestations. This is reflected in an individual pathologically pursuing 
reward and/or relief by substance use and other behaviours. Aviel Goodman 
(2008) defines addiction as a condition in which a behaviour that can function 
both to produce pleasure and to reduce painful affects is employed in a pattern 
that is characterized by two key features: (1) recurrent failure to control the 
behaviour, and (2) continuation of the behaviour despite significant harmful 
consequences.  
Although research during the past two decades has increased the under-
standing of the neural processes that underlie addictive behaviour (Weiss and 
Porrino, 2002), this field still requires more investigations and development of 
new treatment strategies. Most research has not considered how affective 
processing may mediate addictive behaviours. Until, researchers have focussed 
more on the neurobiological substrates underlying addiction than on its 
affective components, and paid less attention to how the dysregulation of brain 
reward and stress systems bias addicted individuals towards continued 
substance use (Cheetham et al., 2010). 
Much of the recent progress in understanding the mechanisms of addiction 
has derived from the study of animal models of addiction on specific drugs, 
such as stimulants and alcohol (Shippenberg and Koob, 2002). While no animal 
model of addiction fully emulates the human condition, animal models do 
permit investigation of specific elements of the process of drug addiction. Such 
elements can be defined by models of different systems, models of psycho-
logical constructs such as positive and negative reinforcement, and models of 
different stages of the addiction cycle (Koob, 2006). 
Long-term repeated consumption of ethanol causes adaptation of the brain, 
which may lead to a habitual or even a compulsive use of the drug (Belin et al., 
2009; Everitt et al., 2008). The influence of early environmental factors, such as 
parental loss, physical abuse etc, and other alterations that affect the developing 
brain functions may as a result increase propensity for ethanol addiction (Anand 
and Scalzo, 2000; De Bellis, 2002; de Kloet et al., 2005; Kendler et al., 2000). 
The conditions that lead to excessive alcohol consumption in some individuals 
but not in others are complex interactions between environmental, psychosocial, 
genetic and neurobiological factors (Dick and Foroud, 2003; Kreek et al., 2004) 
and are suggested to be the cause of variations in vulnerability to addiction 
between individuals (DiFranza et al., 2007; Le Strat et al., 2009). In order to 
examine the early-life environment impact on ethanol consumption, underlying 
neurochemical mechanisms and behavioural functions later in life, the maternal 
separation model is commonly used (de Kloet et al., 2005; Holmes et al., 2005; 
Ladd et al., 2000; Pryce and Feldon, 2003). Early social interactions, such as 
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closeness to mother, are known to be essential in order to have a normal social 
behaviour and physiological development (Hofer, 1994; Krinke, 2000). 
Therefore, different manipulations during the three first postnatal weeks, such 
as maternal separation, alter these developmental processes. It is possible to 
simulate variable relevant environmental settings using controlled experimental 
conditions in order to evaluate the short- or long-term outcomes (Ladd et al., 
2000; Pryce et al., 2005). 
Ethanol intake has an effect on different organs and, in the brain, on several 
neurochemical systems, such as those using DA, 5-HT, gamma-aminobutyric 
acid (GABA), glutamate, CRF etc as their neurotransmitter (reviewed in Dick 
and Foroud, 2003). There is strong evidence that monoamine systems are 
involved in addiction process. The DA system appears to be included in 
ethanol-induced effects (Imperato and Di Chiara, 1986; Koob and Le Moal, 
2001). Many studies have reported that the initial rewarding effects of ethanol 
comprise the activation of the mesocorticolimbic DA pathway (also called the 
reward pathway), where DA neurons projecting from the ventral tegmental area 
(VTA) terminate in the forebrain target area, comprising amygdala, NAcc and 
frontal cortex (Everitt and Robbins, 2005; Koob, 2006; Wise, 2008). Additio-
nally, DA system has been indicated to be sensitive to early-life environment. 
Brake et al. (2004) presented that prolonged litter-wise maternal separation have 
lower DA transporter density in the mesolimbic DA pathway in adult male rats. 
Alterated DA levels are further suggested following prolonged litter-wise 
maternal separation compared to short litter-wise (Matthews et al., 2001).  
Many animal and clinical studies are supporting the involvement of the 5-HT 
system in ethanol reward (Boehm et al., 2005; Oreland, 2004; Yoshimoto et al., 
1992). A dysfunction in central 5-HT neurotransmission has been implicated in 
the pathogenesis of ethanol addiction, although mechanisms remain still unclear 
(Boehm et al., 2005; Heilig and Egli, 2006; Yoshimoto et al., 1992). Quite 
recently, a number of gene and early-life environment interaction studies in 
humans and animals have been carried out (Advani et al., 2007; Nilsson et al., 
2005). These studies have been suggested that 5-HTT gene variants and early-
life environment affects the vulnerability to ethanol intake.  
In addition, brain stress response system is hypothesized to be activated by 
acute excessive alcohol consumption, to be sensitized during repeated with-
drawal, and to contribute to the compulsivity of alcoholism. Brain stress system 
is mediated by CRF system and is dysregulated by chronic administration of all 
major drugs with dependence or abuse. As a result, a common response of 
increased corticosterone and amygdala CRF during acute withdrawal from 
chronic drug administration may be observed (Koob, 2008; Rasmussen et al., 
2000).  
The investigation of inter-individual differences in vulnerability to drug 
effects became more significant in 1990s as a response to the work of Piazza et 
al. (1989) who observed that differences in response to novel environment, as 
measured by locomotor activity, would predict the sensitivity to psycho-
stimulants. Compared to LR-rats, HR-rats were found to have higher locomotor 
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activity in the novel test environment and, response to amphetamine and 
cocaine administration, and stronger behavioural sensitization to repeated drug 
treatment. Psychostimulants such as cocaine and amphetamine produce large 
conditioned place preference (Mackey and Van der Kooy, 1985; Spyraki et al., 
1982) and it is generally accepted that DA-ergic neurotransmission is involved 
(Tzschentke, 1998). Since then, the LR/HR feature has been proposed to model 
human trait of vulnerability to drug addiction and sensation seeking (Blanchard 
et al., 2009; Kabbaj, 2006).  
 
 
1.3.3. Rat ultrasonic vocalization: inter-individual differences  
Animal models of affective disorders usually focus on states resembling fear, 
anxiety, neophobia, depressiveness and other expressions of negative affect 
(Harro, 2010; Singewald, 2007) but in recent years, research on depression has 
increasingly paid attention to positive affect (Geschwind et al., 2011; Forbes 
and Dahl, 2005; Fredrickson, 1998; Watson and Naragon-Gainey, 2010). 
Positive affect is defined as a trait that refers to stable individual differences in 
the experience of positive emotions and active engagement with surroundings. 
Positive and negative affect are relatively independent of one another, which 
means that they can occur in a widely varying range of combinations (e.g. an 
individual can be high or low in both traits) (Brudzynski, 2007; Watson and 
Naragon-Gainey, 2010). They may be taken as the subjective components of 
larger biobehavioural systems that have evolved to promote the survival of 
animals. Positive affect is related to the behavioural facilitation system, an 
approach system that directs towards rewarding and pleasurable situations for 
organisms, such as food, shelter, and sex (Naragon and Watson, 2009). 
Nevertheless, animal models for positive affect are scarce: intracranial self-
stimulation (Carlezon and Chartoff, 2007; Sagara et al., 2010), conditioning 
with addictive drugs (Koob, 2009), measurements of sexual behaviour (García-
Horsman et al., 2008; Paredes and Martínez, 2001) and consumption of 
preference of palatable food (Agmo and Marroquin, 1997). However, these 
techniques have confounding factors, such as homeostasis-related motivation 
and general activity. Studying the emotional systems of the animals via possibly 
affectively valenced vocalizations has been a sphere of interest for almost thirty 
years. It is generally accepted that ultrasonic vocalizations (USVs) elicited by 
animals carry a sociobiological significance. Studying these USVs creates an 
opportunity to have a better understanding about their behaviour, nervous 
system functions and affective states, and thereby use this knowledge in 
modelling human affective states (Panksepp, 2007).  
Rats elicit ultrasonic vocalizations in many different social and emotional 
situations and these USVs have been studied mainly in the context of sexual and 
aggressive behaviour (Takahashi et al., 1983), anxiety, after maternal separation 
in rat pups (Brunelli and Hofer, 1996; Sales and Pye, 1974) but also in a few 
other affective states and conditions in rats (Blanchard et al., 1991; Vivian and 
Miczek, 1991). These USVs vary in frequency and duration and it is known by 
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now that we can distinguish at least three different types of ultrasonic vocali-
zations in rats: 1) the 40-kHz vocalizations in rats pups that are maternally 
separated (Hofer and Shair, 1978; Panksepp, 1998; Sales and Pye, 1974); 2) 
USVs with long duration and frequency approximately below the 30-kHz 
(usually termed „22-kHz USVs“) that seem to be the adult counterpart of 40-
kHz calls that are evident in distressing situations (Noirot, 1968; Nyby and 
Whitney, 1978) and 3) short and high-frequent 50-kHz USVs or 
“chirps“exhibited by adolescent and adult rats (Miczek et al., 1991; Sales and 
Pye, 1974). These 22-kHz and 50-kHz vocalizations have been suggested to 
express opposite affective states like aversion and anticipation in adult rats 
(Burgdorf et al., 2001; Knutson et al., 1999). Longer-lasting 22-kHz USVs in 
adult rats are considered to reflect negative affective states and are elicited e.g., 
during social defeat and in response to danger (Blanchard et al., 1991; Sánchez, 
2003; Tonoue et al., 1986; Vivian and Miczek, 1991). In contrast, vocalizations 
in the around 50-kHz frequency range (the so-called "rat laughter") reflect the 
positive affective states such as in observed playfulness, joyfulness (Burgdorf 
and Panksepp, 2001; Knutson et al., 1999; Panksepp and Burgdorf, 2003) and in 
case of sexual behaviour (Barfield et al., 1979; Sales and Pye, 1974). It was 
found that these chirps can be easily induced by tickle-like stimulation delivered 
by an experimenter. This experimental animal tickling procedure mimics the 
stimulation exerted by natural rough-and-tumble play in rats (Burgdorf and 
Panksepp, 2001; Burgdorf et al., 2005; Panksepp and Burgdorf, 2003). These 
50-kHz vocalizations have a positively reinforcing effect as demonstrated by 
elevated operant behaviour and changes in CPP in response to tickling 
(Burgdorf and Panksepp, 2001). 
It has been demonstrated that individuals persistently differ in emotional 
(positive and negative) reactivity and that these individual differences have 
implications for affect, social relationships and well-being (Gross and John, 
2003; Tellegen, 1985). It is clear by now that the 50-kHz ultrasonic vocali-
zations are individually stable (Mällo et al., 2007b, 2009; Schwarting et al., 
2007) and there are differences in the predisposition of animals to respond to 
tickling with low (LC) or high (HC) levels of 50-kHz USVs that are related to 
more general tendency for emotional reactivity of animals over different 
situations (Mällo et al., 2007b, 2009). Different negatively valenced stimuli 
reduce 50-kHz USVs (Knutson et al., 1998). If HC- and LC-rats were exposed 
to a chronic stress regime, stress suppressed the 50-kHz vocalizations, but the 
levels of 22-kHz USVs were increased in LC male rats (Mällo et al., 2009), 
suggesting that in males low inherent positive affectivity predisposes to anxiety 
and affective disorders. 
Brain pathways involved in production of these different types of ultrasound 
can be analyzed through their component neurotransmitter mechanisms. Many 
investigations suggest that anxiogenic stimuli elicit the release of 5-HT, but that 
distinct 5-HT-ergic pathways can make a different contribution (Millan, 2003; 
Morilak and Frazer, 2004). The hippocampal 5-HT-ergic system has been 
acknowledged to mediate the anxiogenic response (File et al., 2000), while 
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chronic stress profoundly affects hippocampal 5-HT-ergic neurotransmission in 
this region, especially in the dentate gyrus (Joëls et al., 2004; McKittrick et al., 
1995). Additionally, changes in 5-HT and its metabolite levels/turnover or 
release following chronic stress in other brain regions have been observed 
(Bekris et al., 2005; Gamaro et al., 2003; Mangiavacchi et al., 2001). It is also 
suggested that 50-kHz USVs are associated with positive affect and reward-
seeking behaviour, which is believed to be mediated by DA-ergic transmission 
(Burgdorf et al., 2000; Mällo et al., 2007b). Indeed, activation of the ascending 
DA-ergic system induces the state with 50-kHz calls, while activation of the 
relevant portion of the ascending cholinergic system invariably induces the 
negative state and elicits 22-kHz calls (Brudzynski, 2007). Fu and Brudzynski 
(1994) showed that injecting of glutamate into the anterior hypothalamic-
preoptic area of the rat brain induced 50-kHz USVs while injection of carbachol 
(a muscarinic cholinominetic agent) into the same brain area contrarily induced 
22-kHz USVs, suggesting that these USVs have different neurophysiological 
and neurochemical mechanisms. Recent studies have revealed that in the medial 
prefrontal cortex, production of the hedonic 50-kHz vocalizations is determined 
by the glutamate system and depends on NMDA receptors levels that is 
increased by rough and tumble play (Burgdorf et al., 2011). 
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2. HYPOTHESES AND AIMS OF THE THESIS 
Inter-individual differences in animal depression-related behaviour and expres-
sion of naturally occurring behavioural phenotypes create an opportunity to 
have a better understanding about the causes of behaviour, nervous system 
function and affective states. This knowledge can be used for modelling human 
affective states. The studies presented in this thesis are focussed on relating 
inter-individual differences in responses of animals to novel environment and 
imitated social stimuli to underlying neurotransmitter system involvement. 
More specific aims of the present thesis are: 
 
 The noradrenergic projections arising from the locus coeruleus are necessary 
for the high expression of exploratory behaviour. To test the hypothesis that 
intact projections of the locus coeruleus are important for full expression of 
the effects of psychostimulants acting directly on the dopaminergic system, 
the effect of denervation of the locus coeruleus with neurotoxin N-(2-
chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on cocaine-induced 
locomotion and place preference in rats was examined (Paper I). 
 In order to test the hypothesis that early environmental experiences would 
cause long-term changes in monoamine systems, and as a consequence, 
would alter the response to ethanol during later life, serotonin and dopamine 
tissue levels in maternal separated male rats after ethanol consumption were 
studied (Paper II). 
 As serotonergic neural circuits have been associated with anxiety- and 
depression-related conditions, the hypothesis that there are differences in 
serotonergic regulation in rats with different exploratory activity was tested 
(Paper III). 
 Glutamatergic neurotransmission has become a target in the development of 
novel antidepressants. To test the hypothesis that there is an involvement of 
glutamate system in individual variation of traitwise expression of 
exploratory behaviour, the glutamate levels in rats with different exploratory 
activity were measured (Paper V). 
 In order to test the hypothesis that there are differences in serotonergic 
regulation between animals with inherent differences in positive affectivity 
after chronic variable stress, the levels of extracellular serotonin, and 
corticosterone levels, were measured in low and high chirping rats under 
chronic variable stress conditions (Paper IV). 
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3. MATERIALS AND METHODS 
3.1. Animals and housing conditions 
Male (Papers I, III-V) or female (Paper II) Wistar rats from Scanbur BK AB, 
Sweden (Papers I–V) or Harlan Laboratories, the Netherlands (Papers I and 
V), were used. All animals arrived to our animal facilities approximately at the 
age of 3 weeks (except in Paper II). The behavioural experiments started when 
the animals were at least 2 months old, except when the juvenile animals were 
the subjects. Rats were housed in groups of four (Papers I, III, IV and V) or 
single-housed (Paper II) in standard transparent polypropylene (Papers I, III–
V) or makrolon cages (Paper II) under controlled light cycle (lights on from 
08:00 h to 20:00 h, and temperature (19–22 °C), with free access to tap water 
and food pellets (diet R70, Lactamin, Sweden). All behavioural experiments 
were carried out when lights were on in an isolated experimental room. The 
experimental protocol was approved by the Ethics Committee of the University 
of Tartu and Uppsala Ethics Committee and the Swedish Animal Protection 
Legislation. 
 
3.2. Drug administration 
DSP-4 was administered in the dose of 10 or 50 mg/kg intraperitoneally (i.p.) 
(expressed as for hydrochloride) (Paper I). Each dose was weighed separately, 
dissolved in distilled water (2 ml/kg) and injected immediately. Cocaine 
hydrochloride was dissolved in distilled water and administered in the dose of 
15 mg/kg in the volume of 2 ml/kg i.p. immediately before conditioned place 
preference trainings (Paper I). Citalopram hydrobromide (1µM) diluted in 
Ringer solution was administered locally via reverse dialysis (Papers III and 
IV). DL-p-chloroamphetamine (PCA) was administered i.p. in the dose of  
2 mg/kg (Paper III). PDC (4 mM) diluted in Ringer solution was perfused via 
the microdialysis probe (Paper V). Control animals received a vehicle injection 
(Paper I). 
 
3.3. Chemicals 
Drugs: cocaine hydrochloride was purchased from Synapharm GmbH & Co. 
KG, Germany; citalopram hydrobromide from H. Lundbeck A/S, Copenhagen, 
Denmark; N-(2-chloroethyl)-N-ethyle-2-bromobenzylamine (DSP-4) from 
AstraZeneca, Södertälje, Sweden; L-trans-pyrrolidine-2,4-dicarboxylic acid 
was purchased from Sigma, St. Louis, MO, USA. Different standard substances 
for high performance liquid chromatography (HPLC) analysis: 5-hydro-
xytryptamine from Sigma, Germany; 3-hydroxytyramine Fluka, Germany; 
homovanillic acid (HVA), normetanephrine (NMN), 3,4-dihydroxyphenylacetic 
acid (DOPAC), 5-hydroxyindoleacetic acid (5-HIAA),  and noradrenaline from 
Sigma, Switzerland; glutamate from Applichem, Germany. 
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Solvents: methanol, ethanol and acetonitrile from Rathburn, Finland. Other 
chemicals for preparing HPLC eluents or Ringer solution: calcium chloride-2-
hydrate and potassium chloride from Riedel-de Haën GmbH, Germany; 
magnesium chloride from Acros, Belgium; sodium chloride from Reanal, 
Budapest; sodium phosphate dibasic and boric acid from Applichem, Germany; 
sodium hydroxide from Applichem, Germany; sodium octanesulphonate from 
Fisher Scientific, UK; ethylenediaminetetraacetic acid from Serva Electro-
phoresis GmbH, Germany; sodium phosphate monobasic dihydrate, citric acid 
monohydrate and sodium metabisulfite from Fluka, Germany. The β-
mercaptoethanol (β-ME) (Applichem, Germany) and o-phthaldialdehyde (OPA) 
(Sigma, Austria) were used to derivatizate glutamate. 
 
 
3.4. Behavioural models and tests 
3.4.1. Maternal separation 
On the day of birth (day 0) (see Figure 1), the sex of each pup was identified 
before they were culled into litters with five males and four females. The litters 
were randomly assigned to one of three rearing environments: 1) daily 15 min 
of individual maternal separation (MS15, n=6 litters), 2) daily 360 min of 
individual maternal separation (MS360, n=6 litters), or 3) standard animal 
facility rearing conditions (AFR, n=7 litters). The separations occurred once 
daily between postnatal days (PND) 1 and 21 as previously described in detail 
(Gustafsson et al., 2008). First, the dam and then the pups were removed from 
the nest. The rat pups were placed individually in makrolon cages (26×20×  
14 cm) containing wood chip bedding material in a warm cabinet (31.5±0.2 °C) 
to avoid hypothermia. These cages were changed every third day. The rat pups 
were separated from each other using a metal cross that divided each cage into 
four compartments. Separation sessions were performed during the light period 
with the first MS15 litter starting at 09:00 and the first MS360 litter starting at 
09:30. During the separations, the dams in the MS15 groups were moved to 
other cages and the pups were returned before the dams. In the MS360 groups, 
the dams were returned to the home cages during the separations and moved 
again before the pups were returned. All litters were weighed on PNDs 0, 7, 16 
and at weaning PND 22. These days were the only occasions when the AFR 
animals were handled before weaning. The litters were weighed with the pups 
kept together and the mean pup per litter was calculated. On PND 22, the males 
were weaned and housed in the same experimental groups with 4–5 males per 
cage (59×38×20 cm) during a period of seven weeks with standard animal 
facility rearing with changes of cages and water bottles once a week from PND 
23 to 67. 
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Figure 1. The scheme of maternal separation and ethanol consumption procedure. 
 
 
3.4.2. Two-bottle free choice between ethanol and water 
The consequences of repeated individual maternal separation on long-term 
voluntary ethanol consumption were examined in adult male rats using the two-
bottle free-choice drinking paradigm (see Figure 1). The rat pups were 
subjected to the MS15, MS360 and AFR conditions until weaning. At age of 10 
weeks, the male rats were divided into water-consuming and ethanol-consuming 
groups. The adult male rats were weighed before access to ethanol and then 
every third day during the ethanol-drinking period. Food intake was measured 
every third day. During the ethanol-drinking period (7 weeks) the rats were 
singly housed (59х38x20 cm cages) with a wooden house per cage a wood chip 
bedding material. The different ethanol concentrations were prepared from 95% 
ethanol diluted in tap water and were room temperature when placed in the 
cages. The rats were given access to a two-bottle choice between water and 
ethanol for seven weeks. The ethanol concentration was gradually increased 
during the first two weeks with access to 2% (v/v) ethanol for four days and 
four days of 4% ethanol followed by six days of 6% ethanol. Thereafter, the rats 
had free access to 8% ethanol and water for five additional weeks. The water-
consuming AFR, MS15 and MS360 groups served as control groups and were 
housed under the same condition but had access to two containing water bottles 
only. Plastic 250-ml bottles with ball-valve nipples (Scanbur BK AB, Sollen-
tuna, Sweden) were used. Bottle positions were randomised every day to avoid 
position preferences and were weighed daily during the seven weeks to measure 
the fluid consumption. All measurements were made in the afternoon. 
 
 
3.4.3. Place preference conditioning and assessment of locomotion 
Place preference conditioning procedure was conducted as described previously 
(Kivastik et al., 1996). Animals were randomly assigned either to cocaine or 
vehicle group and handled in the experiment room for 2 min on 3 consecutive 
days prior to the introduction to the CPP apparatus. On the 9th and 10th day 
after the DSP-4 treatment, rats were placed into the white part of the CPP 
apparatus and were given free access to both compartments for 15 min. The 
latter session was recorded and served as a baseline for place preference 
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conditioning. Next, during eight daily conditioning sessions (days 11–18 after 
the DSP-4 treatment), rats were injected once every other day with either 
cocaine (cocaine group) or distilled water (vehicle group), and then immediately 
confined into the nonpreferred (white) compartment for 30 min. On alternate 
days, all animals were injected with vehicle, and confined into the other (gray) 
compartment. On the 19th day after the DSP-4 treatment, no injections were 
given; rats were initially placed into the nonpreferred chamber and had then free 
access to both compartments for 15 min, their activity being recorded. The 
following measures from the digital recordings were monitored: (1) number of 
entries into the white compartment, (2) time spent in the white compartment, (3) 
line crossings and (4) rearings in the white compartment. In order to estimate 
the effect of denervation of LC on acute locomotion stimulating effect of 
cocaine and possible revelation of sensitization to cocaine, each animal’s first 
and last training in the white compartment (11–12th and 17–18th day after the 
DSP-4 administration) were also recorded and for the first 15 min (1) rearings 
and (2) line crossings were scored (Experiment 1 of Paper I). The Experiment 
2 of Paper I was an exact replication of the acute phase of Experiment 1. 
Schematic overview of the experimental set-up for Experiment 1 and 
Experiment 2 is presented in Figure 2. To replicate the effect of denervation of 
LC on acute locomotion stimulating effect of cocaine, on the 11th day after the 
neurotoxin treatment, rats were either injected with cocaine (cocaine group) or 
vehicle (control group), restricted into the white compartment and for 15 min, 
their activity was recorded and subsequently scored. The animals were 
sacrificed 3 days after the last drug-free CPP test. 
 
 
Figure 2. The principal scheme of place preference conditioning and assessment of 
locomotion in Experiments 1 and 2. 
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3.4.4. Exploration box test 
The exploration box test was conducted as described previously (Harro et al., 
1995; Otter et al., 1997). The exploration box was made of metal and consisted 
of a 0.5×1 m open area (side walls 40 cm) with a small compartment 
(20×20×20 cm) attached to one of the shorter sides of the open area. The open 
area was divided into eight squares of equal size. In the open area, four objects, 
three novel and one familiar (a glass jar, a cardboard box, a wooden handle and 
a food pellet) were situated in certain places (which remained the same 
throughout the experiment). The small compartment had its floor covered with 
wood shavings and was directly linked to the open area through an opening 
(size 20×20 cm). The apparatus was cleaned with a dampened cloth after each 
animal. The exploration test was initiated by placing a rat into the small 
compartment, which was then covered with a lid for the time of the test. A 
single test session lasted 15 min and the following behavioural parameters were 
registered: (1) latency (of entering open area with all four paws), (2) number of 
entries into the open area, (3) time spent exploring on the open area, (4) line 
crossings, (5) rearings, and (6) number of unfamiliar object investigations. To 
provide an index of exploration the scores of line crossing, rearing and object 
investigation were summed for each animal and thus (7) the sum of exploratory 
events obtained. Animals were classified as high or low explorers (HE and LE, 
respectively) as previously described (Alttoa et al., 2005). All animals were 
exposed to the exploration box test on two consecutive days and the categori-
zation as HE and LE was based on the sum of the exploratory events on the 
second day of testing. 
 
 
3.4.5. Tickling-induced ultrasonic vocalization and  
its measurement 
The single-housed rats were given daily sessions of tickling-like stimulation 
that mimics natural rough-and-tumble play in juvenile rats (Burgdorf and 
Panksepp, 2001) and elicits high levels of 50-kHz chirping (Burgdorf et al., 
2005). The tickling procedure was carried out as previously described (Mällo et 
al., 2007b, 2009) and lasted for 14 days. Animals were individually removed 
from home cage into an empty and smaller cage and given 15 s for habituation, 
followed by 15 s of tickling by experimenter. Altogether, four 15 s sessions of 
stimulation were given over 2 min, after which animals were returned to home 
cage and test cage cleaned. A microphone was located about 20 cm from the 
floor of the tickling cage, recording high frequency audio files of the tickling 
sessions, which were later analyzed with the Avisoft SASLab Pro (Avisoft 
Bioacoustics, Berlin, Germany) software, creating spectrograms from which 
USVs were manually counted. Fifty kilohertz USVs were counted and animals 
classified as emitting high or low number of 50-kHz USVs by the median split 
of the average response on days 12–14 of tickling, providing the high chirping 
(HC) and low chirping (LC) groups.  
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3.4.6. Chronic variable stress procedure 
At the age of two months the animals were submitted to CVS. The CVS pro-
cedure used was developed on the basis of previous experiments (e.g. Harro et 
al., 2001). CVS regimen lasted for 4 weeks and comprised of seven different 
stressors each of which was intermittently used once every week: 1) imitation of 
peritoneal injection using special glove with syringe without needle being 
pressed to the body of animal for several seconds; 2) stroboscopic light (for  
14 h, 10 Hz, 2 lx); 3) tail-pinch with a clothes-pin placed 1 cm distal from the 
base of tail (5 min); 4) cage tilt at 45° (for 24 h); 5) strong illumination (900 lx) 
during predicted dark phase (for 12 h); 6) cold (4°C) water and wet bedding 
(400 ml of water was poured on the rats, and the sawdust bedding was kept wet 
for the following 22 h); 7) movement restriction in a small cage (11x16x7 cm) 
for 2 h. The stressors were administered during the light phase of the cycle 
(except for the stressors that lasted overnight).  
 
 
3.5. Chemical methods 
3.5.1. Monoamine measurement from tissue samples with high-
performance liquid chromatography  
Monoamines and their metabolites were assayed by high performance liquid 
chromatography with electrochemical (amperometric) detection. The rat brain 
tissues were homogenized with an ultrasonic homogenizer (Bandelin Sonopuls, 
Bandelin Electronic, Berlin, Germany) in ice-cold solution of 0.1 M perchloric 
acid (30 or 50 μl/mg) containing 5 mM of sodium bisulphite and 0.4 mM EDTA 
to avoid oxidation. The homogenate was then centrifuged at 14.000 rpm for  
10 min at 4°C. Aliquots (10 μl) of the obtained supernatant were chromato-
graphed on a Luna C18(2) column (150 x 2 mm, 5 μm). The separation was 
done in isocratic elution mode at column temperature of 30 °C using the mobile 
phase containing 0.05 M sodium citrate buffer at pH 3.7, 0.02 mM EDTA,  
1 mM KCl, 1 mM sodium octanesulphonate and 7.5% acetonitrile. The 
chromatography system consisted of an isocratic pump (Hewlett Packard HP 
1100), a temperature-regulated autosampler, a temperature-regulated column 
compartment and an HP 1049 electrochemical detector (Agilent, Waldbronn, 
Germany) with glassy carbon electrode. The measurements were done at an 
electrode potential of +0.7 V versus the Ag/AgCl reference electrode. The limits 
of detection at signal-to-noise ratio (S/N)=3 were as follows: 0.08 pmol/mg 
tissue for DA; 0.10 pmol/mg tissue for HVA; 0.05 pmol/mg tissue for DOPAC;  
0.08 pmol/mg tissue for 5-HT; 0.04 pmol/mg tissue for 5-HIAA. 
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3.5.2. Monoamine measurement from microdialysates with  
high-performance liquid chromatography 
After four weeks of stress regimen, in vivo online microdialysis procedure was 
carried out as previously (Mällo et al., 2007a) in awake and freely moving 
animals. The principle of working of microdialysis probe (Ungerstedt, 1991) is 
presented in Figure 3. In short, the animals were anaesthetized with chloral 
hydrate (350 mg/kg i.p.) and mounted in a Kopf stereotactic frame. A self-made 
concentric Y-shaped microdialysis probe with 4 mm (Papers III and IV),  
5 mm (Paper III), 7.0 mm or 7.5 mm (Paper V) shaft length; and 1 mm 
(Papers III–V) or 3.0 mm (Paper V) active tip or active membrane on the 
whole length (Paper III) were implanted into brain areas with the following 
coordinates: in PFC: AP, +3.3; ML, +0.8; DV, −5.0 (Paper III); in DG: AP -
4.3; ML: +2.2; DV: –3.8 (Papers III and IV); in CA1: AP: –6.0; ML: –5.6; 
DV: –6.4 (Paper V) and in striatum: AP: +0.7; ML: +3.0; DV: –7.0 (Paper V) 
(according to Paxinos and Watson, 1986). The dialysis membrane used was 
polyacrylonitrile/sodium methalyl sulphonate copolymer [Filtral 12, inner 
diameter (ID): 0.22 mm; outer diameter: 0.31 mm; AN 69, Hospal, Bologna, 
Italy]. Two stainless steel screws and dental cement were used to fix the probe 
to the scull. After the surgery, rats were placed in individual cages (21x36x  
18 cm) in which they remained throughout the rest of the experiment and given 
about 24 h for recovery. After recovery, the animal was connected to the 
microdialysis system and the perfusate with Ringer solution (140 mM NaCl,  
4 mM KCl, 1.2 mM CaCl2, 1.0 mM MgCl2, 1.0 mM Na2HPO4, 0.2 mM 
NaH2PO4, pH=7.2 ) at flow rate 1.5 µl/min discarded during the first 60 min to 
allow stabilization. Then 7 samples of microdialysate were collected, followed 
by perfusion of the 5-HT reuptake inhibitor citalopram (1 µM) for 2.5 h 
(Papers III and IV) or glutamate uptake inhibitor PDC (4 mM) for 1 h (Paper 
V). Fourteen more samples were collected after the cessation of drug administ-
ration. All samples were collected in 15 min periods directly into a 50 µl loop 
(Papers III and IV) or inserts (Paper V) and were measured online (Papers 
III and IV) or offline (Paper V) by using HPLC with electrochemical 
detection.  
All microdialysates were collected in 15 min periods directly into a 50 µl 
loop of the electrically actuated injector, injected automatically into the column 
in order to measure the quantity of monoamine in the samples online. The 
chromatography system consisted of a Shimadzu LC-10AD series solvent 
delivery pump, a Luna C18(2) column (150*2 mm, 5 μm) kept at 30ºC and 
Decade II digital electrochemical amperometric detector (Antec Leyden BV, 
Netherlands) with electrochemical flow cell VT-03 (2 mm GC WE, ISAAC 
reference electrode, Antec Leyden BV, Netherlands). The mobile phase 
consisted of 0.05 M sodium citrate buffered at pH 5.3, 2 mM KCl, 0.02 mM 
EDTA, 4.9 mM sodium octanesulphonate and 18.5% acetonitrile. The mobile 
phase was filtered through a 0.22 μm pore size filter (type GV, Millipore, USA) 
and was pumped through the column at a rate of 0.2 ml/min. Serotonin eluted 
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from the column (retention time 5 min) were measured with a glassy carbon 
working electrode maintained at a potential of +0.4 V versus Ag/AgCl reference 
electrode. Data were acquired using a Shimadzu LC Solution system. Con-
centrations of 5-HT were estimated by comparing peak heights from the micro-
dialysates with those of external standards of known concentration. Baseline 
levels of monoamines were defined as average of four samples (3–6). 
 
Figure 3. The principle of the microdialysis probe. 
 
 
3.5.3. Glutamate measurement from microdialysates with  
high-performance liquid chromatography  
The concentration of glutamate in the microdialysates was determined by using 
high performance liquid chromatography with electrochemical detection as 
described by Donzanti and Yamamoto (1988), with some modifications. A 
sample (7.5 μl) of collected microdialysate was derivatized by with 3.8 μl  
40 mM o-phthaldialdehyde solution (0.04 M OPA; boric buffer pH=9.3; 10 % 
ethanol; 0.04 mM β-ME) for 1.5 min. The derivatization reaction is presented in 
Figure 4. Thereafter, a 10 μl pre-treated sample was injected into the HPLC 
system (Hewlett Packard HP 1100). Samples were chromatographed (retention 
time 6.8 min) (see Figure 5) on a Luna C18(2) column (150×2 mm, 5 μm, 
Phenomenex). The separation was done in isocratic elution mode at column 
temperature of 30 °C using the mobile phase (0.3 ml/min) containing 0.1 M 
phosphate buffer (23 % methanol). The chromatography system consisted of a 
Hewlett Packard HP 1100 Series isocratic pump (G 1310A ISO), a 
thermostatted autosampler (G 1329A ALS), a thermostatted column compart-
ment and an HP 1049A electrochemical detector (Agilent, Waldbronn, Ger-
many) with glassy carbon electrode. The measurements were done at an 
electrode potential of +0.6 V versus the Ag/AgCl reference electrode. Con-
centrations of glutamate were estimated from a calibration graph by comparing 
peak heights from the microdialysates with those of external standards of 
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known concentration of glutamate. The detection limit of glutamate was 1 μM 
for a 2:1 signal-to-noise ratio. Calibration graphs were prepared for each series 
of measurement.  
 
 
Figure 4. Derivatization of glutamate with o-phthaldialdehyde (OPA) and β-mercapto-
ethanol (β-ME). 
 
 
 
Figure 5. Chromatograms of standard and microdialysate. 
 
 
3.5.4. Radioligand binding to serotonin transporter  
Samples from the PFC and hippocampus of LE- and HE-rats were collected for 
the determination of 5-HTT levels by specific binding of [N-methyl-
3H]citalopram as described in Mällo et al. (2007b). The PFC samples were 
collected from the right hemisphere (contralateral to the microdialysis site) of 
the frozen brains of the animals that had undergone the microdialysis experi-
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ment immediately before the probe localization determination, while the hippo-
campus samples were collected from the right hemisphere of naive animals that 
were decapitated and brains immediately dissected on ice. The cortical tissue 
were homogenized in 5 ml of homogenization buffer (50 mM Tris-HCl, 
pH=7.4) by Bandelin Sonopuls sonicator (three passes, 10 s each). The 
membrane fragments were collected by centrifugation at 30 000×g for 20 min at 
4 ºC and washed by homogenization and centrifugation for two more times. The 
final pellet was resuspended in 100 vol (ww/v) of the incubation buffer (50 mM 
Tris-HCl, 120 mM NaCl, 5 mM KCl, pH=7.4). Binding of [N-methyl-
3H]citalopram (75 Ci/mmol, Amersham Biosciences) was carried out by 
incubating membranes (1 mg of tissue per tube) in incubation buffer with 
different concentrations of radioligand (0.3–3.5 nM) for 60 min at 25 °C. Non-
specific binding was determined in the presence of 1 µM nonradioactive 
fluoxetine. The reaction was stopped by rapid filtration through GF/B glass-
fiber filter (Whatman Int. Ltd., presoaked with 0.3% polyethyleneimine before 
filtration) and the filter were washed three times with ice-cold incubation 
buffer. The filter were kept in 4 ml of scintillation cocktail (OptiPhase HiSafe3, 
Wallac Perkin Elmer Life Sciences, Cambridge, UK) overnight and counted 
using a RackBeta 1219 liquid scintillation counter (Wallac Inc., Gaithersburg, 
MD, USA). Raw data was analyzed by means of a non-linear least squares 
fittings using GraphPad PRISMTM (GraphPad Software, San Diego, CA, USA) 
software. 
 
3.5.5. RNA isolation, cDNA synthesis and  
quantitative real-time PCR 
Brains of LE- and HE-rats, not used in any experiments but for the selection, were 
dissected and used for total RNA isolation and cDNA synthesis as described 
previously (Pruunsild et al., 2007). Levels of total BDNF and NGF mRNA were 
quantified with qPCR Core kit for SYBR® Green I No ROX (RT-SN10–05NR, 
Eurogentec, Belgium). All reactions were performed on LightCycler 2.0 thermo-
cycler (Roche) using the following temperature cycling conditions: 10 min at 95°C 
(initial denaturation step), then 45 cycles of 5 s at 95 °C, 10 s at 55 °C and 10 s at  
72 °C. All PCR reactions were performed in triplicate and normalized to β-actin 
(ACTB) mRNA levels. The following primers were used: BDNF_cod_s 
GGCCCAACGAAGAAAACCAT, BDNF_ cod_as AGCATCACCCGGGAA 
GTGT, NGF_s TTGCCAAGGACGCAGCTTTCTA, NGF as CAACATG 
GACATTACGCTATGCA, ACTB_s ATGCAATCCTGTGGCATCCAT and 
ACTB_as CCACCAGACAGCACTGTGTTG. The Q-PCR data were expressed as 
BDNF or NGF mRNA levels relative to the reference β-actin mRNA levels, with 
the expression level of 1.0 for a randomly selected sample. 
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3.5.6. Plasma corticosterone measurement  
Animals were decapitated immediately after the collection of the last micro-
dialysis sample, and trunk blood was collected into pre-cooled tubes containing 
K3 EDTA. The blood samples were kept on ice and centrifuged after every  
4 animals (4 000 × g for 10 min at 4°C). Plasma was pipetted into Eppendorf 
tubes and stored at –80°C until the assay. Plasma samples were thawed on ice 
and lightly vortexed and diluted 15 times. Plasma corticosterone was measured 
by ELISA (Correlate-EIA™, Assay Design, Inc., Ann Arbor, MI 48108, USA) 
according to directions of manufacturer. The sensitivity of this assay is  
27 pg⁄mL. Upon completion of the assay, 96-well plates were read at 405 nm on 
a Labsystems Multiskan MCC/340 microplate reader. 
 
 
3.6. Data analysis 
In Paper I, data from the behavioural test and HPLC measurements were 
analyzed with two-factor analysis of variance (ANOVA), the Toxin (0 vs 10 vs 
50 mg/kg of DSP-4) and Treatment (Vehicle vs Cocaine) as independent 
variables. Where appropriate, a repeated measures factor (Day) was added.  
In Paper II, overall differences between MS15, MS360 and AFR groups 
assessed using the Kruskal-Wallis analysis followed by the Mann-Whitney U-
test. Overall changes in fluid intake during the five-week access to 8% ethanol 
were analyzed using the Friedman test followed by the Wilcoxon signed rank 
test. Between-group differences in changes over time were compared using the 
Kruskal-Wallis analysis. Two-way ANOVA was used to examine the effect of 
rearing environment (MS15 vs MS360 vs AFR) and age (PND 0 vs 7 vs 16 vs 
22) on the mean pup weight in litters during the postnatal period. The individual 
body weight in adult rats before and after water/ethanol consumption was 
compared using a repeated ANOVA. Differences in the levels of monoamine 
and their metabolites were analyzed using ANOVA. The effect of ethanol 
intake (ethanol vs water) the effect of rearing environment (MS15 vs MS360 vs 
AFR) and the interaction between ethanol and rearing environment were 
examined using two-way ANOVA. Fisher`s Protected Least Significant 
Difference (PLSD) test was used for post-hoc comparisons. Statistical analyses 
were performed with Statview v5.01 (SAS Institute Inc., Cary, NC).  
In Paper III, data were analyzed with one-factor (Exploration) ANOVA, 
with a repeated measure (Sample) added for microdialysis data. Data of the 5-
HTT binding were analyzed by means of non-linear least squares regression 
using a commercial program GraphPad PRISMTM (GraphPad, San Diego, CA, 
USA) and obtained parameters compared with t-test. Q-PCR data are expressed 
as BDNF or NGF mRNA levels relative to the reference β-actin mRNA levels 
and were analyzed with a two-factor ANOVA. When appropriate, post hoc 
comparisons were made with Fisher’s PLSD test. All statistics were made using 
StatView 5.0 software (SAS Institute Inc., Cary, NC, USA). 
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In Paper IV, data were analyzed with a two-factor (Chirping x Stress) 
ANOVA with repeated measures for the weight gain and microdialysis data and 
with a two-factor (Chirping x Stress) ANOVA for the corticosterone data. 
When appropriate, post hoc comparisons were made with Fisher’s PLSD test. 
Weight gain for a particular day n was calculated by subtracting the day 1 
weight from the day n weight.  
In Paper V, data were analyzed with repeated measures ANOVA. Group 
differences after significant ANOVAs were measured by post hoc Fisher’s 
PLSD test. All statistics were made using StatView 5.0 software (SAS Institute 
Inc., Cary, NC, USA). 
Statistical significance was set at p<0.05 in all analyses. 
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4. RESULTS AND DISCUSSION 
4.1. Neurobiological and behavioural effects of 
denervation of the noradrenergic projections from  
locus coeruleus (Paper I) 
4.1.1. Neurotoxin effect on tissue contents  
of monoamines and their metabolites 
Monoamine and their metabolite tissue levels were measured in hippocampus 
and cortex after administration of two doses (10 mg/kg or 50 mg/kg) of the 
neurotoxin DSP-4, which has a selective effect on NA-axonal terminal fields 
originating from the locus coeruleus (LC).  
More than 3 weeks (23 days) (Experiment I) after the administration of DSP-
4, the higher dose (50 mg/kg) had reduced the tissue content of NA significantly 
in both hippocampus (74%) and frontal cortex (53%) (Table 1), that is, to a 
comparable extent with previous findings (Harro et al., 2000; Kask et al., 1997). 
However, after the lower dose (10 mg/kg) of DSP-4 treatment, NA levels did 
not differ significantly from that of control rats. Similar effect has been found in 
an experiment (Harro et al., 2003) where after 3 days the treatment with the 
same dose of 10 mg/kg DSP-4 reduced NA levels in the frontal cortex by 22%, 
but 1 month later the NA levels were found to be completely recovered. Still, 
20–30% reduction of NA content in the same areas after 3–4 weeks with  
10 mg/kg of DSP-4 treatment has also been observed (Alttoa et al., 2005, 2007). 
It is known that gradual recovery of NA levels after neurodegeneration elicited 
by DSP-4 treatment can occur (Hallman et al., 1984; Srinivasan and Schmidt, 
2004; Szot et al., 2010). The tissue levels of NA were recovered in the DSP-4 
(10 mg/kg) group by the time of sacrifice, but in behaviour – and in DA 
turnover – the functional effects were still observable and roughly similar to the 
effect of the higher DSP-4 dose. Still, NA levels, either at tissue levels or 
measured in extracellular space do not reflect well alterations in NA pathways, 
probably because of large compensatory capacities (Hughes and Stanford, 1998; 
Kask et al., 1997). However, changes in other neurotransmitter systems can 
reflect even small lesions in the NA system (Häidkind et al., 2002), and in the 
present work this is indicated by the reduction of DA turnover after DSP-4 
treatment irrespective to the dose used (see Table 1). 
Animals need to recover after DSP-4 treatment to replete peripheral stores of 
NA, and cocaine conditioning takes several days. As levels of NA recover by 
the time, it appears not possible to measure DSP-4 effect on cocaine con-
ditioning and to use the NA levels to confirm the efficacy of the neurotoxin in 
the same animals. Therefore another, similar experiment (Experiment 2) was 
carried out, in which NA levels were measured earlier – 12–13 days after 
administration with neurotoxin. As we predicted, the NA levels were reduced 
dose-dependently as compared to the controls. Levels of NA were decreased in 
frontal cortex and hippocampus in the lower dose group by 32% and 28%, 
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respectively, and in case of higher dose 74% and 85% respectively (Table 2). 
Therefore, the finding that extensive LC denervation reduces the effect of 
cocaine was confirmed and we can presume that similar reduction in NA 
content also occurred in Experiment 1 during the first CPP training (11th–12th 
day after the neurotoxin administration) as this would also be in line with 
previous studies (Harro et al., 2003).  
Additionally, pre-treatment with DSP-4 has effect not only on the 
noradrenaline but also on other monoamine systems. In the experiments 
described in Paper I, treatment with DSP-4 time-dependently affected DA and 
5-HT levels. In Experiment 1, DA levels in frontal cortex were upregulated. 
Similar upregulation of DA levels has been reported by others (Hallman et al., 
1984; Fortnai et al., 1996) who used near-complete denervation two weeks 
following DSP-4 treatment. In addition, in Experiment 1, DA turnover was 
reduced after DSP-4 pre-treatment irrespective of the dose used. Similar 
outcomes, increased DA levels, was observed in Experiment 2, but the increase 
was not statistically significant. 
Alterations in 5-HT levels also appeared in both Experiments. Higher dose 
of DSP-4 (50 mg/kg) decreased the 5-HIAA levels in frontal cortex. In 
Experiment 2, both doses lowered the turnover of 5-HT (as measured by 5-
HIAA/5-HT ratio) in frontal cortex. In hippocampus the higher dose of the 
neurotoxin reduced 5-HT in hippocampus, but enhanced 5-HT turnover. 
Treatment with DSP-4 has been found to change 5-HT levels and its turnover in 
several studies (Cassano et al., 2009; Dabrowska et al., 2008; Ferdyn-Drosik et 
al., 2010). Nevertheless it is still questioned whether this effect is direct or 
indirect. It seems that this effect is secondary and has no direct established 
behavioural importance. Nevertheless, a possible part of changes in 5-HT 
system and behavioural effects after the DSP-4 treatment still has to be 
considered.
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4.1.2. The effect of locus coeruleus denervation  
on locomotor activity 
The results of this experiment indicate a large decrease in locomotor activity 
effect of cocaine in animals with LC denervation (Paper I Figure 1). Smaller 
dose of DSP-4 was sufficient to reduce the cocaine-stimulated movement 
during the first training in the white compartment (nonpreferred part for 
animals) of the CPP apparatus, the experiment carried out 11–12 days after 
administration of DSP-4. During the last training in the cocaine-paired 
compartment both doses of DSP-4 reduced the number of cocaine-induced 
rearings, but only the higher dose had a decreasing effect [F(2,42)=4.7, p<0.05)] 
on line crossing. This supports the notion that the recovered NA levels in the  
10 mg/kg group were behaviourally relevant. The fact that cocaine still had a 
substantial stimulating effect in animals with denervation on line crossings 
indicates that LC-denervated noradrenergic transmission enhances but is not 
completely required to obtain locomotor responses to cocaine. Although, in 
Experiment 2, there was a confirmation that higher dose of DSP-4 produces the 
reduction of locomotor activating effect of cocaine (Paper I Figure 3), the 
effect of the partial denervation was not significant in this experiment. While 
this could have been because of either different source/age of the animals used 
in this study, or lower locomotor response to cocaine, it suggests that a minor 
reduction in NA function has no robust impact on the motor activating effects of 
cocaine. 
 
4.1.3. The effect of locus coeruleus denervation  
on cocaine-induced place preference 
Cocaine-conditioned place preference was revealed only in rats with an intact 
projection from the LC. Cocaine CPP as measured by increase of time spent in 
the previously cocaine-paired chamber during drug-free conditions before and 
after cocaine-paired trainings, was completely absent after the large lesion of 
LC projections by high dose of DSP-4 (50 mg/kg) (Paper I Figure 2). The 
cause of this effect needs further investigation because it is not quite clear 
whether the attenuation of CPP in LC - compromised animals is attributable to 
attenuation of rewarding properties of cocaine or lesion in contextual learning 
or both. Studies using DSP-4 have suggested lesions in acquisition of contextual 
learning in two-way avoidance paradigm (Archer et al., 1984a; 1984b; Ögren et 
al., 1980). Impaired learning of a spatial discrimination has also been observed 
following treatment with DSP-4 (Archer et al., 1983). On the other hand, 
several studies have been presented that elevation of noradrenergic function 
improve the performance of rodents in attentional set-shifting tasks (Lapiz and 
Morilak, 2006; Lapiz et al., 2007). However, as the locomotor response to 
cocaine was attenuated in the 50 mg/kg DSP-4 group, it can be deduced that a 
crucial part in this effect is due to compromised NA system. It has also been 
reported that local prefrontal cortical NA reduction, which impairs cocaine-
induced DA release, eliminates CPP in mice (Ventura et al., 2007). If NA levels 
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do not to reflect completely the behavioural effects of DSP-4, this might be 
because of mediation by compensatory changes in other neurotransmitter 
systems, such as the dopaminergic pathways. As recent studies have revealed 
that activity in VTA dopaminergic cells is sufficient to mediate place preference 
conditioning (Tsai et al., 2009), one may propose that psychostimulant reward 
depends on both noradrenergic and dopaminergic neurotransmission in this 
brain area. 
 
 
4.2. Ethanol–induced effects on monoamine systems in 
the rat depending of early-life experiences (Paper II) 
4.2.1. Influence of the early environmental effects and voluntary 
ethanol drinking on body weight 
The body weight was measured throughout the experiment to examine whether 
the maternal separation per se resulted in body weight changes and also to 
examine any effects of ethanol consumption on body weight gain.  
In pups, there was a significant effect of rearing environment [F(2, 
64)=14.37, p<0.0001]. Although, all rats showed an increase in body weight as 
supported by the significant effect of age [F(3,64)=1133.98, p<0.0001], no 
significant interaction between rearing environment and age was observed, 
which indicated similar weight gain in the MS15-, MS360- and AFR-rats. In 
adult age, the body weight differed between MS15, MS360 and AFR groups 
[F(5,85)=2.49, p=0.04]. The MS360-rats had lower body weight both in young 
age and in adulthood compared to MS15- and AFR-rats before access to the 
two-bottle free choice between ethanol and water. This indicates that the 
MS360 regime was stressful. There were no significant differences between the 
rats assigned for ethanol or water consumption. Additionally, all rats had an 
increase in weight during the seven-week drinking period [F(1,85)=3784.73, 
p<0.0001] and the weight gain was similar. After drinking period, no diffe-
rences observed between ethanol-drinking AFR-, MS15- and MS360-rats. 
 
 
4.2.2. Early environmental effects  
on adult ethanol and water consumption 
Ethanol and water intake were measured daily during seven weeks of 
continuous access to a free choice between ethanol (concentrations differed 
between days as seen in Figure 1) and water. No differences in voluntary 
ethanol intake were observed between the MS15-, MS360- and AFR-rats during 
the two weeks of increasing ethanol concentration. During the last five weeks 
before sacrifice, the rats had free choice between 8% ethanol and water. No 
differences in ethanol intake between MS15-, MS360- and AFR-rats were seen 
during these five weeks.  
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An overall significant increase of ethanol consumption over time was 
observed in all groups (Figure 6A). The ethanol intake continuously increased 
over time and stabilised towards the end of the drinking period. All groups 
consumed more ethanol during the last week compared to the first week but still 
no differences in consumption increase were observed between groups. 
Therefore, the assessment of the neurobiological consequences of voluntary 
ethanol consumption could be performed without the confounding effects of 
differences in ingested ethanol.  
There were no differences between the experimental groups in water 
consumption. However, water intake was lower during the last week compared 
to the first week in all groups [MS15 (Z=−3.40, p=0.0007), MS360 (Z=−2.90, 
p=0.004), AFR (Z=−3.18, p=0.002)], with a similar decrease. Additionally, 
there was no change in total fluid consumption between the first and last week 
during access to 8% ethanol. 
 
 
 
Figure 6. Ethanol and water consumption in adult rats. The rats were exposed to 
individual maternal separation for either 15 min (MS15) or 360 min (MS360) or AFR 
during the postnatal period. The rats had free access to ethanol and water using a two-
bottle paradigm for seven weeks. The graphs illustrate the weekly 8% ethanol (A) and 
water (B) consumption during the last five weeks before the neurochemical analysis. 
Data are shown as medians and 1st and 3rd quartiles (box). The whiskers extend to 
show the highest and lowest values. *p<0.05; p<0.01; compared to the ethanol intake 
the preceding week in each group (Wilcoxon signed rank test). +p<0.05; ++p<0.01; 
compared to the first week with 8% ethanol in each group (Wilcoxon signed rank test). 
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4.2.3. Early environmental and ethanol effects  
on levels of dopamine and serotonin 
The experiment herein revealed that voluntary ethanol consumption for seven 
weeks induced a few region-and transmitter-specific changes depending on the 
ingested ethanol dose. DA, 5-HT and their metabolites were measured in the 
frontal cortex, cingulate cortex, nucleus caudatus, NAcc, VTA, amygdala, 
hippocampus and dorsal raphe nucleus (DRN). 
The amount of metabolite formed is indirectly reflected in the changes of the 
amount of neurotransmitter being released. Therefore, alterations in the meta-
bolite formation are often used as indicators of neuronal activity (McBride et 
al., 1989). The results of turnover of tissue levels of 5-HT and DA and statis-
tical tests are presented in Table 3. In mesocorticolimbic (largely dopaminer-
gic) areas, including NAcc, VTA, DRN, cortex and amygdala, the results 
pointed to environmental-induced alterations in 5-HT and DA transmission. 
In nucleus accumbens, the control MS360-rats had lower 5-HT levels in the 
NAcc than both MS15 and AFR groups, indicating environmentally induced 
adaptation in this system that might lead to changes in adult behaviour. Lower 
5-HT levels in rats subjected to the longer separation, which served as a risk 
environment, is in line with previous studies in rats with different innate 
propensity for high voluntary ethanol consumption (Arborelius and Eklund, 
2007). The facts that ethanol-drinking MS15-rats had more significant lowering 
of 5-HT levels compared to water-drinking MS15-rats (Paper II Figure 2A), 
and that 5-HIAA levels (Paper II Figure 2B), were not affected by ethanol, 
combined in an increased 5-HIAA/5-HT (Table 3) ratio in MS15-rats. An 
increase in 5-HT turnover could indicate an increase of 5-HT activity after 
ethanol consumption. 
Many studies accept a regulating role of 5-HT on the central DA activity 
(reviewed in Di Matteo et al., 2008). Also it is suggested that 5-HT inhibits DA-
dependent reward networks in the NAcc, and that 5-HT plays an important role 
in reward-related behaviour (Liu and Ikemoto, 2007; Nakamura et al., 2008). 
However, in the present work, no differences in DA measures after seven weeks 
of ethanol consumption were observed in this region.  
It is indicated that the serotonergic innervation of the NAcc originates from 
the DRN (Van Bockstaele et al., 1993). In the present work, there were no 
changes either in 5-HT or 5-HIAA levels in the DRN area as a result of ethanol 
consumption. However, the DOPAC+HVA/DA ratio was increased, indicated 
an increase in dopaminergic activity. Ethanol-induced effects in DRN were 
observed similarly to NAcc only in MS15-rats. Dopamine-containing nerve 
terminals in the DRN are demonstrated to regulate 5-HT neurons (Ferré and 
Artigas, 1993) that are further linked with the NAcc in an interactive neuronal 
circuit (Brown and Molliver, 2000; Daw et al., 2002). Altogether, shorter time 
maternal separated rats were more sensitive to ethanol-induced changes in the 
NAcc and DRN compared to other groups and there was dependence on 
previous early environmental experiences in the DRN response to ethanol. 
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Table 3. 5-HT turnover (A) and DA turnover (B) expressed as the ratio between the 
transmitter and metabolite(s) in adult rats. The rats were subjected to three different 
rearing conditions during the first three postnatal weeks, 15 min individual maternal 
separation (MS15), 360 min individual maternal separation (MS360) and animal facility 
rearing (AFR). The tissue levels were measured in different brain areas after seven 
weeks of voluntary ethanol intake (E) and water intake (W). 
 
Brain region    AFR MS15 MS360 
A. 5-HIAA/5-HT     
Frontal cortex W 0.310±0.015 0.288±0.012 0.286±0.010 
 E 0.299±0.012 0.295±0.011 0.274±0.008 
Cingulate cortex W 0.687±0.072 0.706±0.097 0.728±0.068 
 E 0.689±0.058 0.731±0.061 0.749±0.039 
Dorsal raphe nucleus W 1.358±0.044 1.353±0.094 1.414±0.075 
 E 1.389±0.065 1.489±0.075 1.591±0.119 
Nucleus accumbens W 0.809±0.026 0.707±0.038 0.811±0.045 
 E 0.848±0.028 0.820±0.030a 0.826±0.033 
Ventral tegmental area W 0.890±0.071 0.804±0.053 0.978±0.077 
 E 0.968±0.081 0.863±0.046 1.029±0.082 
Amygdala W 0.426±0.037 0.472±0.037 0.551±0.020 
 E 0.510±0.033 0.503±0.031 0.437±0.031a,b 
B. DOPAC+HVA/DA; DOPAC/DA in amygdala 
Frontal cortex W 0.811±0.051 0.611±0.076 0.539±0.051 
 E 0.667±0.067 0.755±0.086 0.684±0.058 
Cingulate cortex W 0.647±0.028 0.732±0.027 0.743±0.043 
 E 0.718±0.037 0.695±0.030 0.703±0.039 
Dorsal raphe nucleus W 0.540±0.058 0.380±0.045 0.463±0.045 
 E 0.557±0.046 0.551±0.044a 0.528±0.036 
Nucleus accumbens W 0.180±0.005 0.178±0.010 0.180±0.006 
 E 0.186±0.005 0.189±0.006 0.183±0.006 
Ventral tegmental area W 0.890±0.071 0.804±0.053 0.978±0.077 
 E 0.968±0.081 0.863±0.046 1.029±0.082 
Amygdala W 0.183±0.030 0.244±0.055 0.248±0.031 
  E 0.263±0.033 0.181±0.028 0.158±0.025b 
Data are presented as mean ± SEM 
a p<0.05 compared to the corresponding water drinking group 
b p<0.05 compared to the corresponding AFR group  
 
 
In frontal cortex, adult water-drinking MS360-rats had lower levels of 5-HIAA 
compared to the water-drinking MS15-rats (Paper II Figure 3B). Low frontal 
cortical 5-HIAA levels have been linked to impulsiveness (Higley et al., 1991), 
which in turn is closely linked to addictive behaviour both as a cause and a 
consequence (de Wit, 2009). Thus changed 5-HT transmission in the MS360-
rats could have been affected their ethanol consumption in a long-term 
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perspective. Interestingly, the differences in the levels of 5-HIAA between 
MS15- and MS360-rats were eliminated in ethanol-drinking rats, which 
demonstrates that 5-HIAA levels increased as a result of ethanol consumption in 
MS360-rats. It has been reported that the ethanol-preferring P line rats had 
increased 5-HIAA levels in the frontal cortex after ethanol injections (Murphy 
et al., 1988). Thus, results from the present study indicate that ethanol elicited 
effects in MS360-rats reared in a risk environment resembling rats that had been 
selectively bred for ethanol preference. Finding of no effect on DA levels in 
ethanol-drinking rats in this area is consistent with results described by Murphy 
et al. (1988), that acute ethanol had no influence on DOPAC and HVA levels in 
ethanol-tolerant rats. 
In amygdala, which is implicated in development of addiction, probably 
because of its key position in regulation of emotion (Koob, 2011; Weiss and 
Porrino, 2002), the water-drinking MS360-rats had similar 5-HIAA levels, but 
lower 5-HT levels compared to AFR-rats (Figure 7). Thus, as a result the 5-
HIAA/5-HT ratio was higher in the MS360-rats (Table 3). Therefore, the 
present work provided evidence of different ethanol-induced effects in the 
amygdala depending on the early environmental rearing condition. Additio-
nally, these results may indicate altered 5-HT neurotransmission in rats reared 
in a more stressful environment (longer maternal separation), and this is con-
sistent with the notion that amygdala is sensitive to early stress (Pechtel and 
Pizzagalli, 2011; Tottenham and Sheridan, 2009). Several studies with animals 
using maternal separation paradigm have also shown that amygdala is a target 
for postnatal influence (Davis and Whalen, 2001; Ebner et al., 2005; Gustafsson 
et al., 2007).  
Voluntary ethanol consumption resulted in opposite effects between MS360- 
and AFR-rats: ethanol caused higher 5-HT levels in the MS360-rats but lower 
5-HT levels in the AFR-rats (Figure 7). These results present definite evidence 
of the influences of early environmental factors on adult responses to voluntary 
ethanol drinking in the 5-HT system. Interestingly, MS15-rats were seemingly 
unresponsive to ethanol consumption in terms of neurochemistry in the 
amygdala compared to MS360- and AFR-rats. This outcome is exciting in the 
light of the proposed role of the amygdala in adaptive processes during chronic 
drug intake (Everitt et al., 2008; Koob, 2003).  
The DOPAC/DA ratio was also affected by ethanol consumption differently 
dependent upon maternal separation. In MS360-rats the DOPAC/DA ratio was 
lower (see Table 3), due to lower DOPAC and higher DA levels, which may 
indicate a lower DA activity. 
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Figure 7. Tissue levels of 5-HT, DA and metabolites in the amygdala. The 5-HT (A), 5-
HIAA (B), DA (C) and DOPAC (D) levels (mean±SEM) in the amygdala of adult 
water- and ethanol-drinking rats are shown. The rats were subjected to different rearing 
conditions during postnatal days 1–21: MS15, MS360 or ARF. *p<0.05, **p<0.01, 
+p<0.05 compared to water-drinking rats within each rearing group (Fisher post hoc 
test). 
 
 
Altogether, these findings on levels of 5-HT, DA and their metabolites suggest 
that maternal separation induces long-term changes in different brain regions 
and transmitter systems. It is known that the effects of a drug, for instance 
alcohol, possibly at the level of the amygdala, modulate individual decision-
making whether to continue drug intake (Belin et al., 2009; Robbins et al., 
2008). The effects of voluntary ethanol consumption on 5-HT and DA measures 
in brain areas that are related to reward and addiction processes were dependent 
on early environmental experience. In this experiment, these effects were most 
distinct in the amygdala. Environmentally induced alterations in response to 
ethanol may contribute to the individual differences in vulnerability for 
addiction.  
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4.3. Neurobiological differences in rats with high and low 
exploratory activity (Papers III and V) 
4.3.1. Extracellular serotonin and serotonin transporter 
The 5-HT-ergic system is well known to play an important role in emotional 
reactivity and anxiety in animals and the greatest interest has been paid to the 5-
HT-ergic function in PFC and hippocampus (Giorgi et al., 2003; Keck et al., 
2005).  
It has previously been found that LE-rats have higher levels of metabolic 
activity in DRN (Matrov et al., 2007) that is a major source of forebrain 5-HT-
ergic innervation, but lower levels of 5-HT in frontal cortical tissue samples 
(Alttoa et al., 2005). Thus, in order to learn more about differences in 5-HT-
ergic regulation in LE- and HE-rats, in vivo microdialysis was used in the 
present work to monitor extracellular 5-HT levels in PFC and DG at baseline 
and also in response to manipulations on the 5-HT-ergic system.  
The baseline levels of 5-HT overflow in PFC and DG were similar in HE- 
and LE-rats, and no differences were detected in parachloroamphetamine-
induced depolarization-independent 5-HT release in these regions (Paper III 
Figure 1). Interestingly, in frontal cortex, the density of 5-HT transporter sites 
was higher in the LE-rats (Paper III Figure 2). Indeed, after local infusion with 
citalopram, the increase in extracellular 5-HT levels in LE animals was higher 
in PFC (Figure 8A). Probably the density of the 5-HT-ergic projections to the 
PFC is higher in LE-rats, resulting in higher extracellular 5-HT levels after 
blockage of 5-HT transporter, while at baseline conditions the greater release of 
5-HT is balanced by the increased reuptake in the LE-rats that we found to have 
higher levels of 5-HTT in this region. Petty et al. (1994) reported that rats with 
higher increase in extracellular levels of 5-HT caused by an inescapable stress 
were more likely to become helpless than rats with less 5-HT increase in frontal 
cortex, although the basal 5-HT levels did not predict the behavioural outcome. 
Giorgi et al. (2003) have reported that higher levels of [3H]-citalopram binding 
to 5-HT reuptake sites and greater increase in 5-HT availability elicited by local 
application of a selective 5-HT reuptake inhibitors in the frontal cortex in 
Roman high avoidance rats. However, some reports have come to the con-
clusion that Roman high avoidance rats reveal less anxiety-related behaviour 
under stressful conditions and also higher novelty-directed, exploratory be-
haviour than Roman low avoidance rats (Pawlak et al., 2008). Thus, it appears 
that both increased and decreased 5-HT-ergic activity in cortex, which has 
extensive influences on many components of forebrain circuits regulating 
anxiety behaviour (Millan, 2003, for review), can be found in animals revealing 
more anxiety-related behaviour. 
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Figure 8. Extracellular serotonin levels in the medial prefrontal cortex (A) and dentate 
gyrus (B) of HE-and LE-rats, after infusion of citalopram. Samples were collected every 
15 min and are presented as percentage of baseline levels (mean of samples 4.–6.). 
Infusion with 1 μM solution of citalopram was made during the collection of samples 
7.–16. *– p<0.01; ** – p<0.01; *** – p<0.0001 difference between HE and LE groups. 
HE – high exploratory activity rats, LE – low exploratory activity rats. Data are 
presented as mean±SEM. 
 
 
Contrarily, in DG (Figure 8B), during citalopram perfusion, the LE-rats had 
lower increase in extracellular 5-HT levels, but this was not accompanied by 
lower binding capacities of 5-HTT in this area. The hippocampal 5-HT-ergic 
system has been associated to mediate anxiogenic responses (File et al., 2000) 
and with dysfunction in hippocampal region, particularly in DG which plays an 
important role in stress response (Airan et al., 2007; Tanti and Belzung, 2010). 
The Wistar-Kyoto strain of rats, that is more anxious and passive in the plus-
maze test than the spontaneously hypertensive rat strain (Durand et al., 1999; 
Pollier et al., 2000), has been reported to have lower levels of the 5-HTT 
binding sites in the hippocampus. Additionally, their extracellular 5-HT levels 
were lower after citalopram perfusion as compared to less anxious sponta-
neously hypertensive rats (Pollier et al., 2000). On the other hand, inbred Lewis 
rats, that are also more anxious in plus-maze, did not differ with regard to  
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[3H]-citalopram binding in hippocampus (Kulikov et al., 1997). In another 
animal model, high anxiety-related behaviour rats showed lower 5-HT release 
in the dorsal hippocampus, which was apparent in response to emotional 
stressors but not under baseline conditions. Nevertheless, these high anxiety-
related behaviour, rats had increased number of 5-HTT binding sites in the 
hippocampus as compared with low anxiety-related behaviour rats (Keck et al., 
2005). 
A possible interpretation for different release of 5-HT after infusion of 
citalopram in DG between HE- and LE-rats may be through differential activity 
of 5-HT1B autoreceptors, which regulate the release of 5-HT by inhibitory 
feedback and have been hypothesized to be hypersensitive in depression and 
anxiety (Moret and Briley, 2000). Additionally, 5-HT1B autoreceptor activity 
has previously been found to be different in PFC and DG (Adell et al., 2001), 
and in learned helpless rats, these receptors are found to be up-regulated in the 
cortex and hippocampus, and down-regulated in the hypothalamus, compared to 
control animals (Edwards et al., 1991). 
Results from other researchers and the present work altogether indicate that 
there are complex relations between anxiety and 5-HT/5-HTT levels, whereas 
both increased and decreased levels of 5-HT are associated with anxiety-related 
behaviours. This is compatible with human studies that have suggested that it is 
rather the deviation from the mean in the serotonergic system that is driving 
anxiety-related behaviour (e.g., Harro et al., 2004). 
 
 
4.3.2. Growth factors 
In left prefrontal cortex, the relative levels of BDNF mRNA were higher in LE-
rats (Paper III Figure 4) as compared to HE-rats, suggesting that BDNF gene 
expression is increased on the level of transcription or mRNA stability. There 
was no difference in NGF mRNA levels or BDNF mRNA and NGF mRNA 
levels in hippocampus between the LE and HE groups. This fits with findings 
that BDNF promotes the function and growth of 5-HT-containing neurones in 
the brain (Altar, 1999). Still, it should be acknowledged that our results are not 
indicative of any direct association between BDNF and 5-HTT expression. 
Nevertheless, these results contradict the common BDNF hypothesis of 
depression, based on findings that stressful conditions decrease BDNF mRNA 
levels (Altar, 1999; Licinio and Wong, 2002). However, several studies have 
found increased BDNF levels in depressive-like states. Angelucci et al. (2000) 
found altered levels of neurotrophins in Flinders Sensitive Line rats, including 
increased levels of BDNF and NGF in cortex and hypothalamus. Some studies 
in rats have found that chronic stress resulted in upregulation of BDNF mRNA 
or protein in hippocampus (Larsen et al., 2010; Schulte-Herbrüggen et al., 
2009). Furthermore, bulbectomized mice that have depressed-like phenotype 
have significantly increased levels of BDNF protein in frontal cortex and 
hippocampus (Hellweg et al., 2007).  
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Clearly, these contradictory results suggest that the participation of neuro-
trophic factors in depression-related disorders is more complex than originally 
presumed. It has to be considered that the change in BDNF levels in rodent 
models of anxiety and depression might indicate an attempt towards neuro-
chemical adaptation. Castrén et al. (2007) suggested that neurotrophic factors 
act in the activity-dependent modulation of neuronal networks, whereas a 
gradual network recovery through activity-dependent neuronal plasticity 
induces the antidepressant effect. 
 
 
4.3.3. Differences in extracellular glutamate levels in the striatum 
and hippocampus in rats with high and low exploratory activity  
The baseline levels of glutamate were comparable with results of others authors, 
both in striatum (Del Arco et al., 2001; Ho et al., 2000; Shakil et al., 2005) and 
hippocampus (Chefer et al., 2011; Matsuno and Inoue, 2008; Takeda et al., 
2006).  
At baseline, there were no differences in striatal extracellular glutamate 
levels between LE- and HE-rats, either in 3-months-old or 11-months-old 
animals. In response to glutamate transporter inhibition with PDC (4 mM), 
glutamate levels raised both in striatum (Figure 9) and in hippocampus (Figure 
10), but the increase in striatum was proportionally higher. Differences in 
glutamate levels between LE- and HE-rats were revealed in striatum, as levels 
of glutamate increased (up to 600%) to a proportionately larger extent after 
PDC infusion in 3-month-old HE-rats [F(1,411)=2.08, p=0.0035]. Similar 
proportional increase (up to 500%) was seen in 11-month-old rats, and again the 
response in HE- and LE-rats was significantly different [F(1,168)=2.4, 
p=0.0014]. Although, the response to inhibition with PDC has previously been 
found to decrease with aging (Del Arco et al., 2001), there was no significant 
difference in increase of glutamate levels between younger and older HE and 
LE groups. 
The glutamate transporter inhibitor PDC blocks the glial glutamate 
transporter EAAT2. It is believed that EAAT2 plays a primary role in 
maintaining extracellular glutamate concentrations below excitotoxic levels 
(Holmseth et al., 2012; Liu et al., 2012; Tanaka, 2000). In an animal model in 
which this glutamate transporter was genetically deleted, EAAT2 was shown to 
be necessary for brain development through regulation of extracellular 
glutamate concentration (Matsugami et al., 2006). Behrens et al. (2002) 
observed that transgenic mice expressing an N-terminal fragment of mutant 
huntingtin (R6/2) had higher striatal glutamate levels compared with controls 
after inhibition by PDC. Additionally, in the R6/2 mice the decrease of EAAT2 
mRNA expression compared to wild type group was also observed, obviously 
resulting in a reduction of transporter function. The fact that blockade of 
EAAT2 reveals differences in extracellular levels in HE- and LE-rats suggests 
that differences may exist in glutamate release and transport between animals 
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with high vs. low novelty-related activity. It could be speculated that there is a 
higher presynaptic output of glutamate in HE-rats, which is compensated for by 
increased glutamate uptake. On the other hand, HE-rats had slightly lower (data 
not shown) striatal baseline levels compared to LE-rats, that contributed to the 
difference in proportional levels after perfusion with PDC. However, if any 
possible natural stimulus affected the balance between release and uptake of 
glutamate, the HE-rats would be influenced to a greater extent. 
 
 
  
 
 
 
Figure 9. Extracellular glutamate levels in the striatum of 3-month-old (A) and 11-
month-old (B) LE- and HE-rats after perfusion of 4 mM PDC. Samples were collected 
every 15 min and are presented as percentage of baseline (mean of samples 4.-7.) levels. 
Perfusion with PDC was made during the collection of samples 8.-11. * p<0.05 
difference between LE and HE group. LE – low exploring rats; HE – high exploring 
rats. 
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No difference in baseline glutamate levels between HE and LE group was found 
in hippocampus. After perfusion with PDC glutamate levels increased a bit 
more than twofold, but without difference between LE- and HE-rats (Figure 
10). Previous reports have suggested that increased hippocampal glutamate 
levels are associated with response to novel environment (Bianchi et al., 2003; 
Takeda et al., 2006). However, another study (Giovannini et al., 2001) found no 
change in hippocampal glutamate levels in response to novelty. In our 
experiment the response to novelty was not measured, but we could not detect 
any difference in glutamate levels in animals with different strategies in novel 
environment, suggesting that the differences observed in striatum were region-
specific. In another animal model, the learned helplessness model of depression, 
the more helpless rat had significantly reduced expression of the EAAT2 in 
hippocampus (Zink et al., 2010). While the LE-rats display a depression-like 
phenotype and had lower glutamate levels after uptake inhibition in striatum, 
this was not found in hippocampus. Nevertheless, the learned helplessness 
model is different from a number of other depression models at least in terms of 
cerebral regional oxidative metabolism (Harro et al., 2011).  
 
 
 
Figure 10. Extracellular glutamate levels in the hippocampus of HE-and LE-rats after 
infusion with 4 mM PDC. Samples were collected every 15 min and are presented as 
percentage of baseline (mean of samples 4.-7.) levels. Perfusion with PDC was made 
during the collection of samples 8.-11. LE – low exploring rats; HE – high exploring 
rats. 
 
 
Compared to LE-rats, HE-rats have higher striatal extracellular dopamine levels 
both in baseline conditions and after administration of amphetamine (Alttoa et 
al., 2009; Mällo et al., 2007a). It is well known that glutamatergic and dopami-
nergic neurotransmission interact in the striatum (Smith and Bolam, 1990). 
There are different mechanisms by which glutamate and dopamine might 
interact (Hernández et al., 2003; Mora et al., 2003; Seeman et al., 2009). Mora 
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et al. (2003) showed that increasing levels of glutamate lead to increasing levels 
of dopamine in striatum, and blockade of ionotropic glutamate receptors 
attenuates the increase of dopamine levels. The spontaneously hypertensive rats 
that are more active in the open field had higher glutamate-stimulated dopamine 
release in substantia nigra, suggesting that altered glutamate regulation of 
dopamine neurons may contribute to novelty response at different levels 
(Warton et al., 2009). Nevertheless, there are no single-valued interactions 
between dopaminergic and glutamatergic transmission (reviewed in David et 
al., 2005). Thus, further studies should elucidate how the interplay between 
dopamine- and glutamate-mediated neurotransmission contributes to active vs. 
passive coping strategies with novelty. 
 
 
4.3.4. Changes in exploratory behaviour and  
striatal extracellular glutamate levels 
Our previous study indicated that the characteristic levels of exploratory 
behaviour are highly persistent at least up to the age of 8 months (Mällo et al., 
2007a). In the present experiments, exploratory activity of some HE-rats had 
significantly dropped by 11 months of age (in 3 out of 7). Interestingly, this 
subgroup differed significantly [F(2,240)=1.5, p=0.028)] from both HE-and LE-
rats at same age, having almost two times higher extracellular striatal glutamate 
levels at baseline (16.2±3.5 μM) (Figure 11). Still, the proportional increase in 
glutamate levels after PDC in this subgroup [former high exploring (HEF) 
group] did not significantly differ from HE- and LE-rats.  
It is well known that pathologically high levels of glutamate can cause 
excitotoxicity (Meldrum and Garthwaite, 1990; Rosenberg et al., 1992) and 
stressful environment might increase extracellular content of glutamate in older 
animals in different brain areas, including in striatum (Lowy et al., 1995; 
Moghaddam, 1993; Smith et al., 2002). Moghaddam et al. (1993) have 
presented a microdialysis study, where 20 min long stressful restraint procedure 
had an enhancing impact on extracellular striatal glutamate levels in rats. It is 
thus tempting to speculate that persistently high levels of glutamate could be 
associated with changes in neuroplasticity that eventually led to the loss of high 
exploring phenotype in these animals. Ho et al. (2000) examined striatal 
glutamate levels in olfactory bulbectomized rats. It appeared that under novelty 
stress condition glutamate levels increased (up to 160%) from the baseline value 
in bulbectomized rats, while no changes were seen in sham-operated rats. The 
most prominent behavioural feature of bulbectomized animals is hyperactivity. 
One could speculate that higher sensitivity to environmental stimuli leads to 
higher levels of striatal glutamate output and hyperactivity, but excessive over-
flow of glutamate eventually causes loss of novelty-related activity. 
Nevertheless, certainly our finding needs to be re-examined with larger 
experimental groups, and the causality of the link between extracellular 
glutamate and changes in novelty-related behaviour experimentally tested.  
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Figure 11. Extracellular glutamate levels in the striatum of 11-month-old LE- and HE-
rats after perfusion with 4 mM PDC. Samples were collected every 15 min. Perfusion 
with PDC was made during the collection of samples 8.–11. * – p<0.05 difference 
between HEF and HE group; # - p<0.05 difference between HEF and LE group. LE – 
low explorating rats; HE – high exploring rats; HEF – former high exploring rats. 
 
 
4.4. Neurobiological differences in rats with high and  
low levels of 50-kHz ultrasonic vocalizations (Paper IV) 
4.4.1. Effect of chronic stress on hippocampal extracellular serotonin 
levels in rats with high and low levels of 50-kHz ultrasonic 
vocalizations 
We have earlier found that stable inter-individual differences exist in the 
expression of 50-kHz USVs, accompanied by behavioural differences in tests 
used in anxiety and depression studies (Mällo et al., 2007b, 2009). In the pre-
sent experiment again large persistent inter-individual differences in emission of 
50-kHZ USVs were observed. Emission of 22-kHz USVs, as being associated 
with negative affectivity, was present in only a few animals, even in these 
individuals at very low levels, and did not differ between the high chirping and 
low chirping groups. 
Chronic variable stress had an effect on body weight gain [F(26,598)=3.28, 
p<0.001]. It decreased weight gain in both LC and HC group (Figure 12), but 
the effect was stronger in the LC-rats. This confirms the effectiveness of the 
applied stress regimen (Harro et al., 2001) and indicates a greater susceptibility 
to stress in LC-rats. A relative decrease in the body weight of stressed rats after 
CVS procedures, as compared to controls, has been observed in many studies 
(Moreau et al., 1992; Nielsen et al., 2000; Willner et al., 1996), including our 
own (Harro et al., 1999; Mällo et al., 2007b, 2009). Our previous finding that 
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body weight gain is affected by chronic stress more in LC- than the HC-rats 
(Mällo et al., 2009) was thus reproduced.  
 
 
 
 
Figure 12. Weight gain in control and stressed LC- and HC-rats (mean ± SEM). 
*p<0.05 difference between LC control and LC stress groups; ¤ p<0.05 difference 
between HC control and HC stress groups. LC – low chirping rats; HC – high chirping 
rats. 
 
 
In the present study, at baseline extracellular levels of 5-HT, there was no 
significant difference between LC and HC animals. Nevertheless, there was a 
main effect of Chirping [F(1,23)=8.82, p<0.01] on baseline extracellular 5-HT 
levels, and a Chirping x Time interaction [F(28,644)=3.25, p<0.0001]; a 
significant Stress x Time interaction was also found [F(28,644)=1.79, p<0.01]. 
This was because after local inhibition of 5-HT uptake by citalopram (1 µM), 
significant differences between the groups emerged. Thus, the increase in 
extracellular 5-HT levels after infusion with citalopram, as compared to 
baseline, was much higher in LC-rats that had been submitted to chronic 
variable stress (Figure 13). The effect of citalopram was also remarkably long-
lasting in this group. Stressed LC group might have responded more to 
microdialysis procedure itself than other groups. Additionally this might explain 
the slightly higher 5-HT levels in stressed LC group immediately before 
treatment with citalopram. However, throughout the experiment, treatment with 
citalopram appeared to be increasing 5-HT overflow especially in the stressed 
LC-rats, as the baseline differences were minor and, when collapsed, not 
statistically significant. 
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Figure 13. Extracellular serotonin levels in the dentate gyrus of LC- and HC-rats after 
local infusion of 1 µM citalopram solution (mean ± SEM). Samples were collected 
every 15 min and are presented as percentage of baseline (mean of samples 4.-6.) levels. 
Infusion with citalopram was made during the collection of samples 7.-16. * p<0.05 
difference between LC control and LC stress groups; # p<0.05 difference between HC 
stress and LC stress groups. LC – low chirping rats; HC – high chirping rats.  
 
 
The reuptake of 5-HT by the serotonin transporter is considered to be the 
critically important link in 5-HT neurotransmission (Blakely et al., 1994; Lesch 
and Gutknecht, 2005). Experiments with 5-HTT knockout mice have shown 
that they have increased anxiety-like behaviours, whereas transgenic over-
expression of the 5-HTT reduces extracellular 5-HT levels and decreases these 
behaviours (Jennings et al., 2006; Wellman et al., 2007). If there were 
differences in 5-HTT expression, this  might explain why LC- and HC-rats had 
different 5-HT levels after 5-HTT blockade with citalopram. Another possible 
mechanism for increased 5-HT levels in LC-rats in DG after local infusion of 
citalopram may be through differential activity of 5-HT1B autoreceptors, which 
regulate the release of 5-HT by inhibitory feedback and have been hypothesized 
to be supersensitive in depression and anxiety (Moret and Briley, 2000). 
Whereas the activity of neurons is almost entirely dependent on oxidative 
metabolism (Wong-Riley et al., 1998), then measurement of differences in 
oxidative metabolism can be used to reveal the underlying neural substrate of 
differences in positive affect and resilience to stress. It has been previously 
found that chronic stress increased oxidative metabolism in male LC-rats 
compared to HC-rats in several brain regions, including hippocampus (Mällo et 
al., 2009). Additionally, in many regions in which chronic stress had no 
significant effect in unselected animals, it increased oxidative metabolism in LC 
animals only (Kanarik et al., 2008). 
Altogether, it may be claimed that CVS appears to modify regulation of 
hippocampal 5-HT-ergic neurotransmission differently in rats with low positive 
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affectivity. This finding supports the notion of greater vulnerability to CVS in 
male rats with low positive affectivity. 
 
 
4.4.2. Effect of chronic stress on plasma corticosterone levels in rats 
with high and low levels of 50-kHz ultrasonic vocalizations 
Corticosterone is involved in physiological systems such as stress response 
(Grippo et al., 2005; Strausbaugh et al., 1999), which is mediated by an in-
creased release of glucocorticoids via the activation of the HPA axis that, in 
turn, is under CRF-ergic control (Arborelius et al., 1999; Koob, 1999). Additio-
nally, stress is strongly associated with multiple changes in 5-HT system 
(Ressler and Nemeroff, 2000), and drugs that enhance brain 5-HT function alter 
circulating concentrations of corticosterone are believed to be mediated by the 
CRF-containing neurons (Grippo et al., 2005; Murphy et al., 1996). It has been 
reported that acute or chronic stress may have a diverse impact on plasma 
corticosterone levels in rats ranging from decreasing (Murison and Hansen, 
2001) and no change (Azpiroz et al., 1999) to an increase of corticosterone 
levels in plasma in rats (Abelson et al., 2005; Bielajew et al., 2002; Grippo et 
al., 2005). The latter is similar to the human cortisol response (Römer et al., 
2009).  
We found that corticosterone levels measured from full blood after the end 
of microdialysis were significantly higher in the stressed LC animals as 
compared to both the unstressed LC group and the respective HC animals 
(Figure 14). While there was no difference between the control LC- and HC-
rats, higher corticosterone in the LC-rats submitted to chronic stress, as 
measured after the microdialysis experiment, indicates that CVS sensitizes the 
stress axis in rats with low positive affect. 
 
 
 
Figure 14. Corticosterone levels in the plasma of LC- and HC-rats (mean ± SEM).  
# p<0.05 as compared to LC stress group. LC – low chirping rats; HC – high chirping 
rats. 
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5. GENERAL SUMMARY 
The present dissertation focuses on the neurochemical mechanisms associated 
with behaviour in depression–related states. Inter-individual differences, that 
are probably caused by variations in the regulation of neurochemical pathways, 
exist between organisms, and are likely to be significant in the pathogenesis of 
affective disorders. Thus the main emphasis of this dissertation is on the use of 
neurochemical techniques in elucidating the biological substrate of inter-
individual differences in affect-related behaviour, including experimental 
manipulations to study possible mediating mechanisms of such differences.  
Exploratory behaviour is very much dependent on the function of the 
noradrenergic projections of the locus coeruleus. All rats with near complete 
denervation of these projections behave in the exploration box test like the 
spontaneous LE-phenotype that has been associated with less efficient dopa-
minergic neurotransmission. The hypothesis was tested that intact projections of 
the locus coeruleus are important for full expression of the effects of psycho-
stimulants acting directly on the dopaminergic system. It appeared that 
extensive denervation of the noradrenergic projections from locus coeruleus 
indeed reduced the effect of cocaine-induced place preference and locomotor 
activation. 
Early life experiences may alter epigenetically the regulatorsof neuro-
chemical mechanisms and thereby influence the behavioural pattern later in life. 
It is increasingly believed that perinatal events are a major, if not the main, 
source of inter-individual differences in childhood and adult behaviour that 
eventually mediate the development of affective disorders. Alcohol use 
moderates the relationship between behavioural traits and psychiatric disorders. 
The hypothesis that ethanol-induced effects on monoaminergic system are 
dependent on early life environment was confirmed. Animals that experienced 
maternal separation had low 5-HT levels in amygdala and responded with an 
increase in 5-HT after ethanol intake, which is a key area in addiction processes. 
Additionally, alterations in dopamine turnover were observed in dorsal raphe 
nucleus. These results suggest that inter-individual differences in neurochemical 
responses to ethanol consumption occur, and can be result of early environ-
mental factors. It should be further examined whether such changes can mediate 
the transition from habitual to compulsive drinking, and contribute to individual 
vulnerability or resilience to addiction, or the comorbidity of addiction with 
affective disorders.  
Studies in the present dissertation indicate that rats with different exploratory 
phenotype differ, in addition to catecholaminergic mechanisms, also with regard 
to regulation of serotonergic and glutamatergic systems. Serotonergic neuro-
transmission in hippocampus and prefrontal cortex was found to be regionally 
differentially regulated in HE- and LE-rats. In prefrontal cortex, the LE-rats had 
higher extracellular 5-HT levels induced by citalopram and higher levels of 
serotonin transporter binding. In dentate gyrus, contrary, the HE-rats had higher 
levels of extracellular 5-HT. LE-rats had higher levels of BDNF mRNA in the 
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prefrontal cortex, supporting the recent claims that the relationship between 
BDNF expression and depression is not simple linear. These results suggest that 
the persistently different profiles of anxiety-related behaviour can be related to 
the differences in the functional qualities of the 5-HT system in these brain 
regions. Additionally, HE-rats had increased levels of glutamate after blockade 
of glutamate transporter in striatum. Thus, the hypothesis that inter-individual 
differences in exploratory behaviour may be related to striatal glutamatergic 
neurotransmission was confirmed.  
Predisposition to express positive affect at low levels had previously been 
linked to vulnerability to depression. We could confirm the higher sensitivity of 
the LC-rats that produce less 50-kHz vocalizations to chronic stress: they gained 
weight more slowly and had higher corticosterone levels measured from full 
blood after acute stress. The hypothesis that LC-rats have differences in 
serotonergic mechanisms after chronic stress was supported by the finding that 
stressed LC-rats had higher extracellular 5-HT levels induced by citalopram in 
hippocampus, where 5-HT-ergic system has been known to mediate response to 
anxious stimuli. These findings support the notion that male rats with low 50-
kHz USVs response to tickling, having lower positive emotionality, are 
behaviourally more vulnerable to stress. 
Taken together, these results suggest that serotonergic, dopaminergic and 
glutamatergic neurotransmission contribute to variations in response to novelty 
and place preference conditioning, and maternal separation and chronic stress in 
adulthood. Consideration of these neurobiological differences between indi-
viduals could lead to novel approaches to more personalized medical treatment 
of depression-related states. 
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SUMMARY IN ESTONIAN 
Indiviididevahelised erinevused rottide afektiivses käitumises: 
neurokeemilised uuringud 
Käesolev doktoriväitekiri keskendub depressiooniga seotud seisundite ja neuro-
keemiliste süsteemide seoste leidmisele, kasutades erinevaid analüütilisi meeto-
deid ning loomkatsemudeleid. Neurokeemiliste, näiteks monoamiinsete süstee-
mide normaalse funktsioneerimise tasakaalu muutumine võib viia mitmete 
meeleolu- ja sõltuvushäirete tekkimiseni. Depressioon, ärevus- ja sõltuvus-
seisundid on ühiskonnas üha levinumad psüühikahäired ning tänu nende mitme-
palgelisele olemusele on nende uurimine ning ravi küllaltki keeruline. Peamised 
sihtmärgid depressiooniga seotud häirete teraapias on siiamaani seotud olnud 
monoamiinergiliste – serotoniini, dopamiini ja noradrenaliini – süsteemide 
talitlusega. Kuna psühhofarmakonide mõju avaldumine on pikaajaline ning 
indiviidid ei pruugi ravile üheselt alluda, siis on kasvanud vajadus täpsemate 
depressiooni ravimise lähenemisviiside järele.  
Depressiooni ja sellega kaasnevaid häireid saab uurida modelleerides nende 
sümptomeid loomkatsemudelitel. Depressiooni ja ärevusega seotud häirete 
uurimisel kasutatakse sageli uudistaval käitumisel põhinevaid teste, kuna 
uudistav käitumine hõlmab uudsest keskkonnast esilekutsutud stiimulit, mis on 
mõjutatud nii uudishimust kui ka potentsiaalsest tekkivast ohust selles 
keskkonnas. Lisaks on leitud, et nii uudistava kui ka sõltuvusega seotud käitu-
mise regulatsioonis omavad rolli just monoamiinsed neurotransmitterid, mille 
süsteemide mõjustamine toob kaasa ka erinevused käitumuslikes aspektides. 
Eelnevalt on näidatud, et katseloomad erinevad püsivalt oma käitumises 
uudses keskkonnas ning indiviididevahelisi erinevusi on ka neurotransmitterite 
regulatsioonis. Käesoleva töö eksperimentides kasutati uudistava käitumise 
uurimisel uudiskasti, kus loomal on vaba valik suunduda uudsele avarale väljale 
või jääda kodupuuri sarnasele kaitstumale alale. Uudistamisaktiivuse põhjal 
eristatakse loomad kas väheuudistavateks (LE) või paljuuudistavateks (HE) 
isenditeks. Madalama uudistamisaktiivusega loomi peetakse depressiivse-
mateks, kuna nad on reeglina ärevamad ning passiivsemad ka teistes käitumis-
testides. Käesoleva töö raames tehtud mikrodialüüsi katsed näitasid, et hipo-
kampuses (hippocampus) ja frontaalkoores (frontal cortex) on serotonergiline 
süsteem erinevalt reguleeritud. LE-rottidel oli frontaalkoores kõrgemad raku-
välised serotoniini tasemed peale serotoniini transpordi inhibeerimist 
tsitalopraamiga ning lisaks ka kõrgem serotoniini transporteri seondumisvõime. 
Vastupidised tulemused ilmnesid hipokampuses, kus kõrgemad serotoniini 
tasemed olid just HE-rottidel. Paljuuudistavatel rottidel olid kõrgemad gluta-
maadi tasemed peale glutamaadi transporteri inhibeerimist PDC (L-trans-
pürrolidiin-2,4-dikarboksüülhape)-ga juttkehas (striatum), kuid mitte hipo-
kampuses. Seega järeldub, et indiviididevahelised erinevused uudistavas 
käitumises võivad olla seotud lisaks serotonergilisele ka glutamatergilise 
närviülekandega.  
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Uudistav käitumine on suurel määrav sõltuv sinava tuuma (locus coeruleus) 
noradrenaliini projektsioonidest. Rotid, kellel on antud süsteemi kahjustus, 
käituvad uudiskasti testis nagu LE-fenotüüp, mida on seostatud madalama 
dopaminergilise neurotransmissiooni efektiivsusega. Käesolevas töös uuriti, kas 
sinava tuuma projektsioonid on olulised dopaminergilisele süsteemile toimi-
vatele psühhostimulantide efektidele. Leiti, et ulatuslik sinava tuuma projekt-
sioonide kahjustus närvitoksiiniga DSP-4 [N-(2-kloroetüül-N-etüül-2-bromo-
bensüülamiin] vähendas psühhostimulandi kokaiini poolt stimuleeritud koha-
eelistust ja liikumisaktiivsust. 
Varasemalt on leitud, et elusündmused varajases elustaadiumis võivad 
omada mõju neurokeemiliste süsteemidele ning seeläbi mõjustada käitumis-
mustreid hilisemas elus. Seetõttu uuriti antud doktoriväitekirjas, kas alkoholist 
tingitud efektid monoamiini süsteemidele on sõltuvad varajasest elukesk-
konnast. Selleks kasutati varajases eas emast eraldamist, mis mõjub noortele 
poegadele kui stressirikas keskkond. Lisaks mõõdeti rottidel alkoholitarbimise 
mõju monoamiinide sisaldusele erinevates ajupiirkondades. Selgus, et nendel 
alkoholi tarbinud loomadel, kes olid noores eas emast kaua eraldatud, olid 
serotoniini tasemed madalamad just mandelkehas (amygdala), mida seostakse 
enim just sõltuvushäirete tekkimisega. Siit järeldub, et varajases eas toimuvatel 
sündmustel on oluline mõju alkoholi tarbimisele ning serotonergilise süsteemi 
toimimisele.  
Viimastel aastatel on negatiivsete afektiivsete seisundite kõrval hakatud 
spekuleerima positiivse emotsionaalsuse võimaliku rolli üle depressiooni kuju-
nemisel. Vähenenud võime väljendada positiivset emotsionaalsust on eelnevalt 
seostatud kõrgema tundlikkusega depressioonile. Positiivset emotsionaalsust on 
võimalik uurida mõõtes rottide ultraheli-häälitsusi. Nüüdseks on leitud, et 
rottidel on püsivad indiviididevahelised erinevused nende 50-kHz ultraheli 
häälitsustes (piuksudes) ning rotid eristuvad vähe- (LC) ja palju- (HC) 
piuksuvateks loomadeks. Käesolevas töös mõõdeti rottidel eksperimentaatori 
tekitatud kõdistamisest tingitud 50-kHz ultraheli häälitsusi ning uuriti kroonilise 
stressi mõju serotonergilisele süsteemile hipokampuses ja frontaalkoores. Leidis 
kinnitust, et LC-rotid on kroonilisele stressile vastuvõtlikumad: nad võtsid 
kaalus aeglasemalt juurde ning peale stressi olid neil kõrgemad verest määratud 
stressihormooni, kortikosterooni, tasemed. Hüpotees, et LC-rottidel on erine-
vused serotonergilises mehhanismis peale kroonilist stressi, sai kinnitust: LC-
rottidel olid hipokampuses kõrgemad tsitalopraamist tingitud serotoniini 
tasemed. Nendest tulemustest saab järeldada, et isased vähepiuksuvad rotid on 
madalama positiivse emotsionaalsusega ning on stressile vastuvõtlikumad.  
Käesoleva töö tulemustest võib kokkuvõttes järeldada, et rottide käitu-
muslikud erinevused uudses keskkonnas ja erinev tundlikkus stressile, mis on 
kas eristatud spontaansete püsivate eelistuste mõõtmise kaudu või eksperi-
mentaalselt esile kutsutud, sõltuvad serotonergilise, dopaminergilise ja gluta-
matergilise närviülekande toimimise iseärasustest. Neid iseärasusi arvesse 
võttes võib jõuda depressiooniga seotud seisundite uudsete ning personaalsete 
farmakoloogiliste ravimeetoditeni. 
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